Management of multivessel CAD in STEMI

Mechanical complications

Revascularization in ACS with cardiogenic shock

0/3-hour ESC algorithm

2MACE score

10-year ASCVD risk

20-year ASCVD risk

30-year ASCVD risk

5-year risk estimate

12-lead electrocardiogram (ECG)

1-year mortality

1-year survival

2-year survival

3-year survival free of heart transplant

5-year survival

5-year amputation-free survival

5-year survival after aortic repair

10-year survival

10-year follow-up

30-day mortality

30-day readmission

2-D echocardiography

3-dimensional echocardiography

3-dimensional transesophageal echocardiography (TEE)

3-dimensional strain analysis

3-D CT scanning

4-D computed tomography

4-D flow MRI

3-D cardiovascular magnetic resonance (CMR) imaging

18F-FDG PET

22q11.2 deletion syndrome

3-vessel coronary artery disease

2-vessel disease with proximal LAD involvement

Coronary artery stenosis >50%

6-minute walk test (6MWT)

6-minute walk distance (6MWD)

4-factor prothrombin complex concentrate (4-PCC)

5 A’s behavior change framework

3-generation family history

99mTc-PYP scintigraphy

99th percentile upper reference limit

A to Z trial (Aggrastat to Zocor Study)

A2/P2 mitral valve scallops

Abdominal aortic aneurysm (AAA)

AAA growth rate

AAA repair

AAA management strategies

AAA-related rupture

AAA-related mortality

Abdominal aortic aneurysm screening

Abdominal aortic ultrasound

Abdominal adiposity

Abdominal pain

Abdominal distention

Abnormal ankle–brachial index (ABI)

Ankle–brachial index (ABI)

ABI surveillance intervals

Abnormal blood pressure response to exercise

Abnormal electrocardiogram

Abnormal cardiovascular function

Ablation therapy

Ablation outcomes

Ablation safety

Ablation efficacy

Ablation failure

Ablation complications

Ablation-related adverse events

Ablation vs antiarrhythmic drug therapy for atrial fibrillation

Access to cardiovascular care

Accessory atrioventricular pathways

Accessory pathway ablation

Absolute ASCVD risk

Absolute risk reduction

Abscess

Intracardiac or paravalvular abscess

Academic Research Consortium high bleeding risk criteria

ACC (American College of Cardiology)

ACCF (American College of Cardiology Foundation)

ACC/AHA clinical practice guidelines

ACC/AHA pooled cohort equations

ACC/AHA primary prevention guidelines

ACC/AHA secondary prevention guidelines

ACC/AHA hypertension guidelines

ACC/AHA heart failure guidelines

ACC/AHA atrial fibrillation guideline

ACC/AHA valvular heart disease guideline

ACC/AHA aortic disease guidelines

ACC/AHA peripheral artery disease guidelines

ACC/AHA coronary revascularization guidelines

ACC/AHA guideline recommendations

ACC/AHA joint guideline committees

ACCP antithrombotic therapy guidelines

Accreditation Council for Graduate Medical Education (ACGME)

ACE (angiotensin-converting enzyme)

ACE inhibitors

ACE inhibitor therapy for HFrEF

ACE inhibitor intolerance

ACE2-mediated viral tropism

Acetylcholine coronary function testing

Activated clotting time

Activated partial thromboplastin time

Activated prothrombin complex concentrate

Active bleeding on anticoagulation

Active systemic infection

Active malignancy

ACTION trial

ACTION ICU risk score

Activin signaling inhibitors

Activity monitoring and tracking

Adult congenital heart disease (ACHD)

ACHD clinical classification

ACHD specialty centers

ACHD cardiologist care

ACHD guideline-directed management

ACHD mortality risk scores

Acquired heart disease

Acquired von Willebrand syndrome

Acute coronary syndrome (ACS)

ACS management guidelines

Acute aortic syndrome imaging criteria

ACTA2 mutation–associated aortopathy

Thoracic aortopathy genetic variants

ACTC1 gene

Acromegaly-related cardiomyopathy

Acromegaly-associated heart failure

AACVPR (American Association of Cardiovascular and Pulmonary Rehabilitation)

AAPA (American Academy of Physician Assistants)

AATS (American Association for Thoracic Surgery)

Abbott (cardiovascular device manufacturer)

Abbott Laboratories

Abbott Vascular

Abiomed

AbbVie

ABC (Association of Black Cardiologists)

ABCD trial (Appropriate Blood Pressure Control in Diabetes)

Abciximab

ACUITY trial (Acute Catheterization and Urgent Intervention Trial)

Acute and chronic heart failure diagnosis guidelines

Acute and chronic heart failure in congenital heart disease (ACC/AHA statement)

Acute angle of coronary artery takeoff

Acute angulation of the left coronary artery

Acute aortic disease

Acute aortic dissection

Acute aortic dissection diagnostic imaging

Acute aortic intramural hematoma (IMH)

Acute aortic rupture

Acute aortic regurgitation (AR)

Acute aortic pathology

Acute aortic syndrome (AAS)

Acute aortic syndrome classification (IRAD system)

Acute atrial fibrillation (AF)

Acute cardiac care

Acute cardiovascular events

Acute cardioversion

Acute chest pain

Acute congenital heart disease (ACHD)

Acute coronary event

Acute coronary event classification (STEMI vs. NSTEMI/ACS)

Acute coronary event complications

Acute coronary intervention

Acute coronary syndrome (ACS)

ACS differential diagnosis

ACS guideline / management / toolkit / algorithm

ACS management algorithms

Acute COVID-19 cardiovascular syndrome

Acute decompensated heart failure (ADHF)

Acute decompensation of chronic heart failure (HF)

Acute heart failure (HF)

Acute HF with preserved vs. reduced ejection fraction

Acute hypotension

Acute illnesses

Acute inflammatory milieu

Acute kidney injury (AKI)

AKI after coronary procedures

Acute kidney injury as a cardiovascular complication

Acute limb ischemia (ALI)

Acute lower extremity / lower-limb ischemia

Acute management of cardiogenic shock

Acute medical management of aortic dissection

Acute myocardial infarction (MI / AMI)

Acute myocardial infarction with heart failure

Acute myocardial ischemia

Acute myocardial dysfunction without prior HF

Acute non-ischemic myocardial injury

Acute myocarditis

Acute mitral regurgitation (MR)

Acute severe symptomatic MR

Acute severe AR surgical emergency

Acute outcomes

Acute pancreatitis (risk from hypertriglyceridemia)

Acute pericarditis

Acute phlebotomy (250–500 ml blood removal)

Acute presentation

Acute pulmonary edema

Acute pulmonary hypertension

Acute rate control

Acute renal failure

Acute respiratory distress syndrome (ARDS)

Acute reversibility studies during cardiac catheterization

Acute stroke

Acute type A aortic dissection

Acute type B aortic dissection

Acute versus chronic ischemia

Acute vs delayed inadequate LAAO occlusion

Acute vs chronic valve disease

AD (type A) aortic dissection with distal extent

ADA (American Diabetes Association)

ADAM trial (Aneurysm Detection and Management)

ADAMTS19 gene mutation

Adaptive cardiac resynchronization therapy (Adaptive CRT)

Adaptive servo-ventilation

Adaptive trials

Added fats

Added sugar

Added sugar (risk factor for cardiovascular disease)

Added sugars

Addiction therapy

Additional surgical or device therapy

Adjunctive therapy

Adjunctive catheter ablation

Adjuvant (adjunctive) revascularization procedures

Administration route (IV, oral, continuous infusion)

Administrative and accreditation terms

Administrative / claims data for cardiovascular research

Adolescence to young adulthood (13–18 years) CHD care

Adolescents / young adults

ADONIS study (American-Australian-African Trial)

Adrenergic agonists

Adrenergic receptor stimulation

Adrenomedullin

ADSORB trial (Acute Dissection: Stent Graft or Best Medical Therapy)

Adult care hospitals

Adult congenital aortic valve interventions

Adult congenital cardiac clinic

Adult congenital heart association (ACHA)

Adult congenital heart disease (ACHD)

ACHD specialist / program / fellowship / management strategies

Adult HCM management strategies

Adult ICD decision-making

Adult single ventricle clinic

Adults with Eisenmenger syndrome clinical characteristics

Adulthood (18–80+ years) CHD care

Adult-onset hypertrophic cardiomyopathy

Advance care planning / directives in heart failure

Advanced (stage D) heart failure

Advanced age (≥75 y)

Advanced cardiac imaging

Advanced cardiac therapies

Advanced care modalities

Advanced congenital cardiac therapies

Advanced CVD (severe cardiovascular disease)

Advanced dementia

Advanced echocardiographic imaging

Advanced heart failure (HF)

Advanced HF therapies (pre-conception, intra-pump, transplant referral)

Advanced HF with preserved ejection fraction (HFpEF) in HCM

Advanced heart failure and transplant cardiologist

Advanced heart failure position statements (ESC, AHA)

Advanced imaging endpoints

Advanced imaging for LV strain and strain-rate

Advanced imaging markers of disease progression

Advanced kidney disease (non-dialysis / in CAD context)

Advanced lipid disorders program

Advanced liver fibrosis

Advanced NYHA class (III or IV)

Advanced practice provider(s) (nurse practitioners, physician assistants)

Advanced reperfusion strategies (e.g., ARREST trial, CARES registry)

Advanced screening strategies for HF (cost-effectiveness, risk prediction)

Advanced therapies (surgical, mechanical support, transplant, mechanical circulatory support, LVOTO relief)

Advanced treatments (LVAD, heart transplant)

Advancing age

Adventitia

Adventitial inflammation

Adverse aortic events

Adverse cardiac events

Adverse cardiovascular events (hospitalization, mortality)

Adverse cardiovascular outcomes (stroke, bleeding, mortality)

Adverse drug effects

Adverse event risk (mortality, HF, stroke, arrhythmia)

Adverse events (e.g., tendon rupture, uric acid increase, AF)

Adverse maternal and fetal outcomes

Adverse outcomes (stroke, thromboembolism)

Advised risk score

Advocacy priorities

Aerobic exercise

Aerobic exercise safety

Aerobic exercise (moderate / vigorous intensity)

Aerobic interval training

Aerobic training

AF (atrial fibrillation)

AF burden / metrics / monitoring / duration / episode duration (>24 h or >5 min)

AF catheter ablation / AF ablation

AF detection from atrial lead

AF diagnostic accuracy

AF duration thresholds

AF episode / frequency / duration

AF initiation triggers

AF management / guidelines

AF progression / prevention

AF recurrence / post-ablation / post-treatment

AF recurrence predictors / prediction

AF prognosis in obesity

AF risk

AF surveillance

AF symptoms

AF-mediated / AF-induced cardiomyopathy

AF-related morbidity

AF-related mortality

AF-related stroke risk / thromboembolic risk

AHRE (atrial high-rate episodes)

AFL (atrial flutter)

AFFIRM study / AFFIRM trial (substudy)

AFFIRM-AHF trial

AF-CHF study / trial

AFICAMTEN clinical trials

Age (general / advanced / ≥60 y / ≥65 y / ≥70 y / ≥75 y / >80 y)

Age at aortic event / age at repair (<6.5 y)

Age of AF onset (<45 y, <66 y)

Age stratification in valve choice (<50, 50–65, >65 y)

Age threshold (≥75 y)

Age-related longevity and valve selection

Age-related risk categories (≥85, 75–84, 65–74, <65 y)

Age- and lesion-related comorbidity burden in CHD

Age- and sex-based ST-elevation thresholds

Age-adjusted HF mortality

Age-appropriate risk factors

Age-based recommendations (≤65, 65–80, >80 y)

Age-dependent valve choice (≤50, 50–65, >65 y)

Age-related susceptibility to AF

Age-specific risk assessment (20–39, 40–59, 60–75, >75 y)

Age-specific risk prediction models

Age-standardized global prevalence rates of AF / AFL

Advancing age

Aggressive aortopathy

Aggressive blood-pressure control

Aggressive cardiovascular phenotype of aneurysms-osteoarthritis syndrome

Aggressive decongestion

Aggressive diuresis leading to LVOTO amplification

Agranulocytosis

AIM‑HIGH trial

AI-guided atrial fibrillation screening

AI-powered imaging analysis for early PAD detection

AMICA trial (atrial fibrillation management in congestive heart failure with ablation)

ANDROMEDA trial (anti-arrhythmic trial with dronedarone)

ALL-IN cluster randomized trial (integrated AF management)
Air embolism (intraoperative)

Air pollution / ambient air pollution / ambient particulate matter exposure / ambient temperature exposure – cardiovascular risk factors

Air versus oxygen therapy in STEMI

Airway compression symptoms (stridor, wheezing)
Akinetic RVOT length ≥55 mm

Anatomic assessment of disease severity

Anatomic characteristics / complexity / lesions / variants / variability / etiology / pattern / or ischemic testing

Anatomical evaluation of disease / repairs / physiologic classification system

Ancillary imaging in ACHD (e.g., CT-FFR)

Anesthesia-related cardiac risk (e.g., QTc prolongation)
AL amyloidosis

Amyloid cardiomyopathy (AL-CM)

Amyloid heart disease

Amyloidosis (cardiac / infiltrative cardiomyopathy / involvement)
Alcohol (risk factor for CVD / tobacco-related risk factor)

Alcohol consumption / use / moderation / abstinence / reduction (light, moderate, binge, ≤1 drink/day women, ≤2 drinks/day men)

Alcohol abuse / alcoholic cardiomyopathy

Alcohol-induced cardiac toxicity

Alcohol-related AF episodes

Alcohol septal ablation (ASA) / outcomes

Added fats / added sugar / added sugars (risk factor for heart disease)
Aldactone (spironolactone)

Aldosterone antagonists (e.g., spironolactone, eplerenone)

Aldosterone antagonist therapy / blockade / pathway blockade / mineralocorticoid receptor blockade
Albiglutide

Alogliptin
Alirocumab (PCSK9 monoclonal antibody)
Allogeneic hematopoietic cell transplantation

Allograft / allograft cryopreservation / tissue exposure / cryopreserved aorta
Amino-terminal pro-BNP (NT-proBNP)

Albumin / albuminuria (≥30 µg albumin/mg creatinine) – renal function as CVD predictor
Amiodarone (antiarrhythmic drug / therapy / rate- or rhythm-control / IV / preoperative prophylaxis)

Amiodarone-associated thyroid dysfunction (hyperthyroidism, hypothyroidism, thyrotoxicosis)

Amlodipine

Alteplase (tPA)

Ambrisentan (endothelin receptor antagonist / therapy)
Anesthesia (epidural / general / local vs. general in aortic surgery)

Anesthesia collaboration / management in ACHD

Anesthetic planning / pharmacology / management for cardiac surgery / pregnancy

Anesthesiologist with CHD expertise
Andexanet alfa (anti-Xa antidote / factor Xa inhibitor reversal agent)
Anemia (cardiovascular impact / in ACS / in heart failure / management with folic acid, iron, transfusions)

Anaphylactic reactions to beta-blockers
Alagille syndrome (JAG1) – peripheral/branch PA stenosis, coarctation, aortic stenosis, septal defects, mid-aortic narrowing

Anderson-Fabry disease (in hypertrophic cardiomyopathy)
Aneurysm (aortic / LV apical / related to dissection / cause)

Aneurysm growth / rate / dilation (≥0.5 cm/yr, >0.5 cm in 6 months)

Aneurysm neck diameter / sac / sac enlargement / thrombosis prevention

Aneurysm repair / aneurysmectomy / surgical aneurysmectomy

Aneurysm rupture

Aneurysm screening / surveillance / size thresholds (≥5.5 cm men, ≥5.0 cm women, ≥6.0 cm)

Aneurysm-related mortality / reintervention / events / death

Aneurysmal aorta / segment / area / degeneration / disease / extension (proximal arch, ascending, descending thoracic aorta)

Aneurysmal pulmonary arteries / sac / segment replacement

Aneurysmal threshold (≥1.5× reference diameter)

Aneurysms-osteoarthritis syndrome
Angina / angina pectoris / chest pain / anginal pain

Angina pectoris

Angina symptoms / anginal symptoms (dyspnea, arm pain with exertion)

Angina frequency / baseline angina frequency

Angina types: stable angina / unstable angina / refractory angina

Angina ongoing / angina under-recognition

Angina quality of life / angina-related QoL

Anginal episodes / anginal symptom burden

Angina prevalence (including PROVIDER evaluation study)
Angiogenesis

Angiogram / angiography (coronary / contrast-enhanced / invasive / vascular imaging)

Angiographic assessment (stenosis ≥50 %, complexity, chronic coronary disease, progression, patterns, hemodynamic significance)

Angiography-guided PCI / angiography-guided strategy

Angiography grade (1–4)

Angiology (clinical specialty)

Angioplasty / percutaneous coronary angioplasty / angioplasty-first vs. bypass-first strategy

Angiosafe / angiosome / angiosome-targeted revascularization / direct pulsatile flow
Angiotensin II receptor blockers (ARB / ARBs / examples: losartan, valsartan, candesartan)

Angiotensin II receptor blockade / antagonists

Angiotensin receptor blockers / therapy for HFREF / general use

Angiotensin-converting enzyme inhibitors (ACEi / ACE-I / examples: enalapril, ramipril, captopril, fosinopril, lisinopril, perindopril, quinapril, trandolapril)

Angiotensin-converting enzyme inhibition

Angiotensin receptor–neprilysin inhibitors (ARNI / sacubitril-valsartan) / therapy in HFREF or ACHD / pre-HF stage B

Angiotensin-neprilysin inhibition / antagonist

Angiotensin-II-dependent TGF-β signaling
Ankle-brachial index (ABI) / measurement / interpretation / diagnostic thresholds (<0.80, ≤0.90, <0.9)

Ankle pulse volume recordings (PVR)
Annular abscess / dilation / hypoplasia

Annular-to-coronary ostial distance (CT measurement for TAVI planning)

Annuloplasty / annuloplasty repair / ring(s)

Annulus area / size / shape / washer technique / rupture
Anomalous aortic origin of coronary artery (AAOCA) / from opposite sinus

Anomalous left coronary artery (ALCA / ALCAPA) / from pulmonary artery

Anomalous right coronary artery (ARCA / ARCAPA) / from pulmonary artery / left sinus of Valsalva

Anomalous origin of coronary arteries / opposite sinus of Valsalva

Anomalous papillary muscle / insertion

Anomalous pulmonary venous connection / return (partial or total) / APVC
Antegrade cerebral perfusion / antegrade perfusion

Antegrade propagation / antegrade propagation of dissection

Antegrade stenting of descending thoracic aorta / proximal descending thoracic aorta
Anterior aortoiliac disease

Anterior free wall

Anterior mitral leaflet extension

Anterior STEMI / antero-apical infarction

Anterior-lateral thoracotomy

Anterior-posterior (annular) dilation
Anthracyclines (doxorubicin, epirubicin, idarubicin, mitoxantrone)

Anthracycline cardiotoxicity / induced cardiomyopathy / anthracycline-related cardiotoxicity
Antianginal medications

Antiarrhythmic agents / drugs / therapy / follow-up / dosing / maintenance of sinus rhythm (examples: amiodarone, metoprolol)

Antiarrhythmic drug therapy (AAD) / medical therapy / therapy in CKD
Antibiotic therapy / prophylaxis / duration / sensitivity data

Antibiotics for Lyme carditis
Ibrutinib and other anticancer therapies with cardiac toxicity
Anticoagulant therapy / anticoagulation (oral, OACs, DOACs, VKAs, warfarin)

Anticoagulant dosing / adjustment / interruption / resumption / titration / drug absorption

Anticoagulation monitoring (INR / last dose / accessibility)

Anticoagulation bridging / strategies / safety profile / target INR (2–3)

Anticoagulation reversal agents / effectiveness / bleeding risk / risk-benefit assessment

Anticoagulation during pregnancy (including mechanical valves / trimesters)

Anticoagulation in atrial fibrillation (valvular / non-valvular / stroke prevention)

Anticoagulation in amyloidosis / VTE prophylaxis / cancer

Anticoagulation-naïve patients / therapy guidance / strategy independent of CHA₂DS₂‑VASc

Anticoagulation-related intracerebral hemorrhage / surveillance / anticoagulation-sparing strategies

Anticoagulation and antiplatelet therapy
Antidepressants (e.g., escitalopram)

Antidepressant effects

Anxiety / anxiety in ACHD / anxiety in perioperative AAA patients
Antiepileptic drugs

Antimetabolites (clofarabine, cytarabine, 5-fluorouracil, capecitabine, gemcitabine)

Antineoplastic drug interactions

Antimicrotubule agents

Anthracyclines (from previous list, if including anticancer drugs)
Antimicrobial agents / therapy / regimens / duration

Antimicrobial therapy examples (e.g., cloxacillin, gentamicin)

Antimicrobial therapy for aortic infections / foot infections

Antimicrobial therapy duration (48 hrs – 1 week / prolonged IV antibiotics)

Antifungal therapy

Antimicrobial stewardship / stewardship for prosthetic vascular infections
Antigen-presenting cells (APCs)

Antineutrophil cytoplasmic antibody (ANCA) / ANCA-related vasculitis / ANCA-related disease

Antinuclear antibody (ANA)

Antiphospholipid antibody syndrome / antiphospholipid syndrome

Anti-double-stranded DNA (anti-dsDNA)

Anti-cyclic citrullinated peptide (anti-CCP)

Anti-HER2 agents

Anti-human leukocyte antigen (anti-HLA) antibodies

Anti-RNA polymerase III

Anti-Scl-70

Anti-SSA (Ro) / Anti-SSB (La)
Antihypertensive agents / drugs / medication / therapy / treatment

Early antihypertensive drug treatment

Antihypertensive medication burden (≥2 drugs / ≥3 classes)

Antihypertensive therapy for aortic injury

Anti-impulse therapy (beta-blockade, antihypertensive therapy)

Anti-hypertensive drug examples (beta-blockers, calcium-channel blockers, diuretics)
Anti-anginal drugs / therapy (e.g., β-blockers, nitrates, ranolazine, nifedipine)

Anti-ischemic effects
Anti-arrhythmic agents / drugs / medication / therapy / follow-up / risk/benefit analysis

Anti-arrhythmic drug therapy (AAD) / therapy for rhythm control

Anti-arrhythmic drug examples → amiodarone, dofetilide, digoxin

Anti-tachycardia pacing (ATP) / ATP algorithms

Anti-arrhythmic effects
Anticoagulation / anti-coagulation therapy

Antithrombotic agents / drugs / therapy / regimens / strategies / prophylaxis / safety / efficacy

Antiplatelet agents / drugs / therapy / regimen / response / efficacy / strategy / guidelines

Antiplatelet therapy (APT / dual therapy / aspirin / clopidogrel / DAPT)

Antiplatelet and anticoagulant therapy

Antithrombin / antithrombin agents

Anti-Xa activity / anti-Xa agents / direct oral anticoagulants / monitoring / levels
Anti-inflammatory therapy / diet

Antioxidant therapy (vitamin C, beta-carotene, multivitamins)

Antioxidants (ascorbic acid, polyunsaturated fatty acids [PUFA] for AF risk in HF)
Antithyroid treatment

Aorta

Aortic arch / arch anatomy / arch zones (0–5)

Aortic branches / branch vessels / branch vessel involvement / arch branch vessels

Aortic root / sinus segment / root anatomy / root dimensions / root area / cross-sectional area / indexed area / aortic area-height ratio

Aortic ascending aorta

Aortic isthmus / isthmus ratio / stenosis / rupture

Aortic bifurcation

Aortic lumen / orifice

Aortic wall / medial layer / wall abnormalities / wall integrity / wall remodeling / wall biomechanics / wall stress / wall thickening / wall false lumen

Aortic aneurysm (general, AA, AAA, ascending, thoracic, abdominal, saccular, pseudoaneurysm, infra-inguinal/popliteal)

Aortic aneurysm growth / growth rate / sac diameter / surveillance / rupture risk / rupture / diameter thresholds

Aortic dissection (general, type A, type B, acute, chronic, distal to graft, TAD, DeBakey classifications)

Aortic dilation / dilatation / root dilation / aortopathy / enlargement

Aortic ectasia / elongation / expansion

Aortic atheroma / atherosclerosis / plaques / calcification / sclerosis

Aortitis / aortic inflammation / involvement in giant cell arteritis / Takayasu arteritis

Aortic coarctation (native, repaired)

Aortic injury (blunt traumatic, classification schemes, management)

Aortic thrombus / mural thrombosis / thromboembolism

Aortic pseudoaneurysm / anastomotic pseudoaneurysm

Aortic sarcoma / tumor
Aortic pressure / diastolic pressure equilibration

Aortic afterload

Aortic gradient

Aortic velocity / vmax / transvalvular gradient

Aortic stiffness / stiffness index

Aortic volume
Aortic imaging (CT angiography, MRI, FDG-PET, echocardiography, TEE)

Aortic imaging techniques / standards / surveillance schedule / monitoring frequency

Aortic measurement standards / diameter measurement / size / indexing / size index (ASI / AHI) / diameter-height ratio

Aortic size thresholds / growth thresholds

Aortic registry / quality initiative data
Aortic repair / reconstruction / replacement / resection / grafting / endovascular repair / endografting

Aortic repair types: open surgery, endovascular repair, prophylactic, urgent

Aortic replacement / replacement indications / surgical criteria / timing / techniques

Aortic root repair / remodeling / reconstruction / valve-sparing procedures (David procedure, reimplantation)

Aortic valve surgery / repair / replacement / valve-sparing operations / SAVR / AVR

Aortic balloon valvuloplasty

Aortic stump oversewing

Aortic translocation
Aortic valve (AV) anatomy / leaflets / cusp prolapse / adhesion / tethering

Aortic valve disease (stenosis, insufficiency/regurgitation, calcification, congenital)

Aortic valve intervention / replacement / repair / prosthetic choice (mechanical, bioprosthetic)

Aortic valve hemodynamics (flow velocity, gradient, Vmax)

Aortic valve pathology / molecular genetics / complications / endocarditis

Aortic valve surgical planning / indications / timing / durability / reoperation
Aortic rupture / rupture risk / incidence / free vs. contained

Aortic dissection risk / risk assessment / thresholds / detection scores (ADD-RS)

Aortic complications / adverse events / mortality / outcomes

Aortic events (dissection, rupture, aneurysm growth, surgery)

Aortic surveillance / monitoring / post-repair follow-up / imaging intervals

Aortic disease (clinical statements, guidelines, TAD, natural history, epidemiology, pregnancy-specific risk)
Aortic biomechanics / geometry / contour defects / knob disruption

Aortic cross-clamping / cross-sectional area / cross-section-to-height ratio

Aortic involvement in systemic conditions (connective-tissue disorders, familial hypercholesterolemia, Turner’s syndrome)

Aortic pseudoaneurysm / sac thrombosis

Aortic pulmonary collaterals / transposition

Aortic surgical zones / landing zone definitions (0–4)
Aortobifemoral bypass

Aortocaval fistula / aortocavitary fistula

Aortoenteric fistula / aorto‑enteric fistula

Aortoiliac disease / occlusive disease / lesions / PAD involvement / femoropopliteal / infrapopliteal segments

Aortoiliac arterial segment / aortoiliac-femoral occlusive disease

Aortopathy (general) / aortopathic conditions / associated with bicuspid aortic valve / ≥5 cm diameter / connective-tissue disorders

Aortopathy management during pregnancy

Aortopulmonary collaterals / aortopulmonary arteriovenous shunt / fistula / shunt closure

Aorto‑aortic tube grafting

Aorto‑iliac arterial intervention / appropriate use
Arrhythmia (general) / atrial / ventricular / tachyarrhythmias / bradyarrhythmias / post-operative / post-cardioversion

Arrhythmia burden / detection / monitoring / progression / recurrence / substrate identification / management / treatment / strategies

Arrhythmic events / life-threatening arrhythmias / arrhythmic death / arrhythmic phenotypes / arrhythmic risk / risk scores / risk stratification

Arrhythmia-induced cardiomyopathy

Arrhythmogenic cardiomyopathy (ACM) / arrhythmogenic right ventricular cardiomyopathy (ARVC) / arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) / arrhythmogenic substrate

Arrhythmia surgery (Maze procedures)

Arrhythmias during exercise testing / during pregnancy / post-Fontan / in adults after Rastelli surgery

Apical hypertrophy / apical hypertrophic cardiomyopathy / apical aneurysm / apical outpouching / apical myectomy / apex-AMI trial / apical site pacing / apical sparing of LV longitudinal strain / apically displaced papillary muscles / apical point of maximal impulse
AP (accessory pathway) / AP classification (IA, IC–D, etc.)

APT – antiplatelet therapy

Apixaban / ARTESIA trial

ARNI – angiotensin receptor–neprilysin inhibitor

ARB – angiotensin receptor blocker / agents / class (losartan, valsartan)

Arterial aneurysm

Arterial embolism / thromboembolism / thrombosis / occlusion

Arterial intermittent pneumatic compression devices

Arterial lactate (≥2.5 mmol/L)

Arterial line / vascular access

Arterial load / stiffness / tortuosity

Arterial phase imaging

Arterial revascularization / stenosis

Arteriopathy clinic / arteriovenous malformations / arteriovenous fistula-related HF

Arterial switch operation (d-TGA / Jatene procedure)
Appropriate use criteria (AUC) for cardiac imaging / echocardiography / vascular diagnostics / multimodality imaging / congenital heart disease

ARIC study / ARIC risk score (atherosclerosis risk in communities)

ARISTOTLE trial (apixaban efficacy)

ARREST trial

ARC-HF trial (ablation vs. rate control in persistent AF + HF)

Area under the curve (AUC, pharmacology / clinical scoring)
Artificial intelligence (AI)

AI for atrial fibrillation management

AI risk prediction

AI and machine learning in cardiology

AI-based perfusion mapping

AI–ECG (AI-ECG)
Ascending aorta

Ascending aorta aneurysm / thoracic aneurysm (TAA) / AAA

Ascending aorta dilation / dimensions

Ascending aorta procedures / repair / replacement / root replacement surgery

Ascending aortic calcification (porcelain aorta)

Ascending aortic cannulation / complications

Ascending thoracic aorta / thoracic aortic graft

Ascending aortic aneurysm outcomes / surgery
Aspirin (acetylsalicylic acid, ASA)

Aspirin (antiplatelet therapy / monotherapy / for primary prevention / low-dose 75–100 mg, 81 mg daily)

Aspirin dosing: low-dose (81 mg) vs high-dose (162–325 mg) / maintenance dose (75–100 mg/day) / loading dose (162–325 mg)

Aspirin use (cardiovascular prevention, pre-hospital, transplant patients)

Aspirin hypersensitivity / desensitization / contraindications / induced hemorrhage / discontinuation strategy

Aspirin therapy for pericarditis

Aspirin for asymptomatic atherosclerosis (AAA trial)
ASCVD – atherosclerotic cardiovascular disease

ASCVD event risk / events / risk / risk calculator / high-risk clinical factors / prediction models / estimate / risk factors

Assessment of cardiovascular risk / chest pain for CAD / ischemic myocardium in AF patients

Asymptomatic adult cardiac risk assessment
ASD – atrial septal defect / closure

AT – atrial tachycardia

Atrial arrhythmia (general, including flutter / post-closure / recurrent)

Atrial arrhythmia burden / recurrence / detection / suppression (drug trials)

Atrial cardiomyopathy / contraction / dysfunction / ectopic beats / electromechanical delay / electrophysiology / electrophysiology abnormalities / enlargement / fatty infiltration

Atria stroke-risk score
AS – aortic stenosis / asymptomatic AS / severe AS

Asymptomatic aortic regurgitation / severe AR / AR with normal LV function

Atrial annular dilation
Atenolol

Atorvastatin (10–80 mg, ≥40 mg)

ARNI – angiotensin receptor–neprilysin inhibitor

ARB – angiotensin receptor blocker (losartan, valsartan)

Apixaban (ARTESIA trial)
Atherogenic lipoproteins

Atheroma / atherosclerosis / vascular calcification (in CKD) / peripheral arteries / lower extremities

Atherosclerotic disease / cardiovascular disease / heart disease / occlusive disease / risk / pathways / plaque / burden / instability / volume

Atherosclerotic TAA / atherosclerotic vascular disease / atherothrombosis / atherothrombotic events

ARIC study / ARIC risk score / atherosclerosis risk in communities

Risk reduction strategies
Athlete / athlete population / competitive athletes / athlete’s heart / differential diagnosis / activity restrictions
ASAP study / ASAP-Too trial

Atlas study (lisinopril low vs high dose)

Assent-3 trial
Atrial fenestration

Atrial size / dilation / structural abnormalities / stunning

Atrial septal defect (ASD) / ASD closure / ASD / patent foramen ovale (PFO) / atrial septal dilation / atrial septal defects

Atrial switch (Senning/Mustard procedures / surgically induced / operation / repair)

Atrial tissue / myocyte hypertrophy / interstitial collagen / fibrosis / scarring / substrate

Atrial functional mitral regurgitation

Atrial overdrive pacing / atrial pacing / algorithms / lead / pacemaker lead

Atria risk score

Atriopulmonary Fontan / atriotomy scars

Atrioesophageal fistula
Atrial fibrillation (AF) / AFib

AF as comorbidity in HF

AF in valvular heart disease (VHD) / non-valvular / obesity / post-operative / subclinical / device-detected / silent

AF in adult congenital heart disease / pediatric and young adult populations

AF incidence in cancer subtypes

AF management / guidelines (AHA/ACC/HRS) / strategies / therapy outcomes / prevention

AF ablation / on uninterrupted oral anticoagulation

AF burden / recurrence / progression / early-onset, “lone” AF

AF and stroke risk / mortality / quality of life / ventricular fibrosis / weight management

AF classification / clinical outcomes / economic evaluation / follow-up investigation (AFFIRM)

AFTR trial (ablate and pace trial)

Atrial flutter (AFL) / typical & atypical / atypical non-cavotricuspid macroreentrant

Atrial tachycardia (AT) / atrial tachyarrhythmias / atypical atrial arrhythmias

Atrial high-rate episode (AHRE / device-detected)

Atrial fibrillation–associated thromboembolism

Atrial tachyarrhythmia–related AV arrhythmias (refractory)
AV block / AV nodal block / high-grade AV block

AV junction ablation / AV nodal ablation / AV nodal blockers / AV nodal blocking agents / AV nodal ablation strategies

AV synchrony / AV dyssynchrony / AV conduction / AV conduction abnormalities / AV conduction block

AV valve dysfunction / failure / function / regurgitation / replacement / surgery (systemic AV valve repair)

AV septal defect (AVSD) – partial / complete

AV node / displacement / ablation (AVNA)

Atrio-ventricular junction ablation / AV junctional radiofrequency ablation
Autonomic nervous system (ANS) / dysfunction / dysregulation / modulation / nerve sprouting / denervation / neuropathy

Autonomic disorders / dysfunction in amyloidosis / hyperinnervation
Autosomal dominant inheritance / transmission of TAA

ATTR-CM (transthyretin amyloid cardiomyopathy) / ATTR-V (variant) / ATTR-WT (wild-type)
Atriclip device / Atricure

Automated algorithm detection of AF / automated algorithms for AF detection
ATTEST trial

AUGUSTUS trial (antithrombotic therapy after ACS/PCI in AF)

AVID trial (antiarrhythmics versus implantable defibrillators)

A-HeFT trial (African-American heart failure trial)

AVOID trial (air versus oxygen in STEMI)
Autogenous vein / autogenous vein graft / bypass / conduit / surgery / femoral vein autograft

Autologous vein graft

Autograft aortic root replacement

Axillary / axillofemoral bypass / cannulation

Azygous vein / azygous continuation of inferior vena cava

AVR – aortic valve replacement
Azathioprine (DMARD)
B-type natriuretic peptide (BNP) / BNP testing / natriuretic peptides

Bicarbonate

BGN (biglycan, extracellular matrix protein)

Beta-carotene supplementation

B vitamins and omega‑3 fatty acids (cardiovascular effects)
Balloon angioplasty / dilatation / valvuloplasty / occlusion / test occlusion

Balloon aortic valvuloplasty (BAV) / balloon dilation of the aortic valve

Balloon mitral commissurotomy / valvotomy / valvuloplasty (BMV)

Balloon-expandable percutaneous valves / prostheses / pulmonary valve / valve (e.g., Sapien 3)

Balloon-expanded stent

Bare metal stent (BMS) / bare-metal femoropopliteal stent / stents

Bifurcated grafting / bifurcation lesion / bifurcation lesion management

Bioprosthetic valve replacement / bilateral bioprosthetic valve replacement

Bisleaflet mechanical AVR (aortic valve replacement)

Bidirectional cavopulmonary shunt (Glenn shunt) / bidirectional shunt / shunting / anastomosis

Balloon occlusion of the aorta / balloon test occlusion
Bentall procedure

Bariatric procedures / surgery (gastric bypass, sleeve gastrectomy, adjustable gastric banding)

Baseline aortic imaging / coronary imaging / MRI/CT / TEE / TTE

Basal anterior septum / basal septal hypertrophy

Bilateral antegrade cerebral perfusion / bilateral cerebral perfusion

Bilateral aortic injury (BAAI)

Baffle leak / obstruction / stenosis / closure / intervention (e.g., intratrial)
Beta-blockers / therapy / medications / optimal doses / uptitration

Beta-blockers (non-vasodilating, cardioselective, av-nodal blockers)

Beta-blockers in aortic dissection

Beta-blockers in pregnancy / postpartum

Beta-adrenergic blockade / beta-adrenergic blocker therapy

Beta-blockers as adjunct to ARB therapy

Beta-2 agonists

Bempedoic acid / ATP citrate lyase inhibitor / Bempedoic acid + ezetimibe combination therapy

Benzphetamine

Atorvastatin and other statin analogues were covered in previous batches
B Braun Medical

Berlin Heart Excor

Balloon catheter

Ball-in-cage valve

Basket trials (device / procedural studies)
Bicuspid aortic valve (BAV) / BAV disease / bicuspid valve phenotype / BAV-associated aneurysm / bicuspid vs tricuspid aortic valve outcomes / bicuspidoid aortic valve phenotyping

Barlow’s valve

Balloon-expandable prostheses / valves
Behavior modification / therapy / behavioral coaching / counseling / change techniques

Behavioral interventions for tobacco cessation / support

Barriers to care (geographic, insurance, socioeconomic)

Barriers to physical activity in HCM patients

Binge drinking
Bacteremia

Bacterial aortitis

Bacterial endocarditis

Bacterial sepsis (cardiovascular impact)

Behçet disease / Behçet’s disease
BCL2-like protein 12 (BCL2L12)

Beta-myosin heavy chain 7 (MYH7)
BASIL-2 trial (bypass vs angioplasty for severe leg ischemia)

Beautiful trial (ivabradine in CAD with LV dysfunction)

Bari 2D trial results

BBMeta-HF (beta-blockers meta-analysis)

BEST trial (beta-blocker evaluation of survival)

BEST-CLI trial
Back pain

Bicycle exercise testing

Bifid uvula

Biliary excretion (liver metabolism of amiodarone)

Benchmarking across centers / performance measures

Benefit assessment / benefit-risk assessment

Bendopnea
Biochemical cardiac biomarkers

Biochemical screening

Biomarker analysis / assay / domain / testing / utilization in ACS

Biomarkers: BNP, NT-proBNP, troponin, high-sensitivity troponin, desmosine, proteomics, hs-CRP

Biomarkers for AF and stroke prediction

Biomarkers for aortic risk stratification

Biomarkers for heart failure (B-type natriuretic peptide, NT-proBNP)

Biomarkers for risk stratification in heart disease

Biomarkers in asymptomatic aortic valve disease

Biomarkers in HF therapy optimization

Biomarkers of cardiac damage, injury, inflammation, strain

Biomarker-guided therapy

Bioimage study (personalized statin allocation)

Bioimpedance
Bioavailability / pharmacokinetics / pharmacodynamics of diuretics

Biologic disease-modifying antirheumatic drugs (DMARDs)

Biologics / immune-modulating therapies

Biologic-targeted therapy for Takayasu arteritis
Biologic prosthetic valve / biological prosthesis / biological valve / biological valved conduit

Bioprosthesis / bioprosthetic valve / bioprosthetic prostheses

Bioprosthetic aortic valve / mitral valve / pulmonary valves

Bioprosthetic aortic valve durability / leaflet degeneration / stenosis / regurgitation / thrombosis / dysfunction / replacement / surgical or transcatheter

Bioprosthetic TAVI

Bioprosthetic valve degeneration (leaflet calcification, non-coaptation, tear, perforation)

Bioprosthetic valve thrombosis prevention (aspirin, warfarin, low-dose warfarin)

Bioresorbable polymer-coated stent / bio-absorbable stent implantation

Biosense Webster (device manufacturer for cardiac rhythm management)

Biotronik (device manufacturer)
Biphasic cardioversion / energy (≥200 J) / waveform

Biventricular (Bi-V) pacing / cardiac resynchronization therapy (CRT) / BiV pacing

Biventricular defibrillators (CRT-D)

Biventricular circulation / dysfunction / function / global-function index / interaction

Biventricular outflow tract reconstruction / repair / surgical strategy

Biventricular vs right-ventricular pacing (BLOCK-HF)
Birth prevalence of congenital heart defects

Blalock–Taussig–Thomas shunt

Bi-directional cavo-pulmonary shunt
Bleeding / anticoagulation-related bleeding / complications

Major, moderate, minor, life-threatening

Bleeding risk assessment (scores: HAS-BLED, HEMORR2HAGES, ATRIA)

Bleeding risk factors / management / reduction / contraindications

Bleeding risk in HF, ACS, GI bleeding, intracranial bleeding

Bleeding vs ischemic event risk

Bleeding Academic Research Consortium (BARC)
Blood cholesterol / dyslipidemia / management / lipid levels

Blood clot / flow / distribution efficiency / volume / viscosity

Blood culture / diagnostic standards / positivity / negativity / persistently positive

Blood glucose / HbA1c

Blood pressure (BP) / hypertension / management / targets / measurement / control

Systolic BP (SBP) and diastolic BP (DBP)

BP lowering drugs / RAAS inhibitors / beta-blockers

BP response during exercise / homeostasis / cuff gradients / upper vs lower extremity

Blood transfusion / guidelines (AABB, Cochrane review)
Blood pressure (BP) / hypertension / control / management / targets

BP control

BP control including intensive SBP <120 mm Hg

BP management (general, hypertension, diabetes)

BP targets (<130/80 mm Hg; 120–129/<80 mm Hg; ≤130 mm Hg systolic / ≤80 mm Hg diastolic)

BP lowering / BP-lowering therapy / BP-lowering treatment / drugs (β-blockers, ACE inhibitors, calcium antagonists, diuretics)

BP measurement (home, office, electronic)

BP reduction / trajectories / variation

Blood-pressure-related vascular mortality

Blood-flow metrics

Global and regional myocardial blood flow

Perfusion reserve
BNP / B-type natriuretic peptide / brain natriuretic peptide

BNP level >300 pg/mL

NT-proBNP appears in previous batches under biomarkers
Body composition

Body mass index (BMI)

BMI as a risk factor (<21 kg/m² for thyrotoxicosis, BMI-adjusted hazard ratios for AF)

Body-mass-index effects on transplant outcomes

Body surface area (BSA)

BSA indexing for aortic dimensions

BSA–adjusted z-score (general & LV wall thickness)

Body size / habitus / perception / misperception

Body weight

Low-weight vs high-weight

Dose relationships

Thresholds (<60 kg)

Body-size normalization of aortic dimensions / body-size–adjusted normal limits

Body temperature regulation
Blowing (major/minor) bleeding
Blunt traumatic aortic injury (BTAI)

Blunt thoracic aortic injury (BTT-AI)

Blunt abdominal aortic injury (BAAI)

Blunt traumatic abdominal aortic injury

Blunt chest trauma

Bowel ischemia (mesenteric ischemia)

Blue-toe syndrome
Bradyarrhythmia / bradyarrhythmias

Bradycardia / bradycardia pacing / rate control

Brady-tachycardia
Bosentan (endothelin receptor antagonist) / therapy

BRAF inhibitor (vemurafenib) / cardiotoxicity
Brain abscess

Brain arteriovenous malformation

Brain infarction / brain stem infarctions

Boehringer Ingelheim

Bovine arch (common innominate and left carotid artery)
Branch artery aneurysm

Branch artery dilation or narrowing

Branch artery occlusion

Branch artery stenosis

Branch endovascular therapy

Branch pulmonary artery (PA) stenosis

Branch pulmonary artery reintervention

Branch pulmonary artery size and flow

Branch stenting

Branch vessel anatomy of the aorta

Branch vessel aneurysm / aneurysmal disease

Branch vessel ostia

Branch vessel perfusion

Branch vessel stenosis

Branched endovascular aortic repair

Branched graft

Branched stent graft
Bridge procedure

Bridge therapy

Bridge to cure

Bridge to decision / bridge-to-decision strategy

Bridge to recovery

Bridge to surgery

Bridge to transplant / bridge-to-transplant (BTT) strategy

Bridge trial

Bridging anticoagulation / bridging therapy
Bypass / vascular bypass

Bypass graft / conduit

Radial artery, ulnar artery, distal radial artery

Bypass graft patency

Bypass graft failure / occlusion

Bypass graft surgery / CABG

Bypass grafting (open or vascular surgery, including internal mammary arteries)

Bypass grafts

Bypass surgery / CABG

Bypass time

Bypass versus angioplasty (BASIL trial)

Bypass angioplasty revascularization investigation 2 diabetes (BARI 2D)
B-type natriuretic peptide (BNP / NT-proBNP)

B-type natriuretic peptide ≥127 ng/L

B-natriuretic peptide (BNP)
Beta-blocker (B-blocker)

Bucindolol
Bromocriptine / bromocriptine therapy

Bumetanide

Buprenorphine treatment

Bupropion (treatment / nicotine replacement / nicotinic antagonist) / bupropion therapyBreastfeeding in heart failure

Breastfeeding-safe medications (ACEi, beta-blockers, diuretics)

Brisk physical activity

Brockenbrough–Braunwald–Morrow sign

Brompton risk score

Bronchial artery erosion

Brugada syndrome

Bruise-control trial

Bruton tyrosine kinase inhibitors (BTK inhibitors)

Body surface area (BSA) indexed parameters

Built environment

Buttock claudication
C2HEST score (coronary artery disease, hypertension, elderly, systolic HF, etc.)

CAHP score (cardiac arrest hospital prognosis)

Calibrated risk scores
CAD / coronary artery disease

Calcific aortic stenosis / calcific aortic valve disease

Calcific mitral stenosis

Calcific valve disease / calcific valvar stenosis / calcification of aortic wall or valves

Cardiac amyloidosis / transthyretin amyloid cardiomyopathy

Cardiac cachexia

Cardiac complications (myocardial injury, arrhythmias, ischemia, failure, death)

Cardiac dysfunction / heart failure / post-exercise cardiac dysfunction

Cardiac embolization / thromboembolic disease (e.g., atrial thrombus, valvular vegetations, intracardiac shunts)

Cardiac fibrosis / maladaptive structural changes

Cardiac hypertrophy / chamber enlargement / pulmonary venous congestion

Cardiac ischemia / acute or chronic ischemia

Carcinoid heart disease / carcinoid syndrome

Cancer-therapy–related cardiomyopathy / cardiotoxicity

Cancer-associated atrial fibrillation / cardiovascular risk

Brugada syndrome / arrhythmogenic disorders
Cardiac arrest (documented, sudden, post-CPR, during transport)

Cardiac arrest resuscitation guidelines

Cardiac arrest studies (e.g., CASH)
Cardiac biomarkers → NT-proBNP, BNP

Cardiac biomarkers of stretch, injury, or strain

Cardiac bio-markers (general)
Cardiac imaging (echocardiography, MRI, CT, CT angiography, PET)

Cardiac computed tomography (CT / CCT / CTA)

Cardiac magnetic resonance (CMR / MRI / perfusion imaging / LVOT evaluation / myocardial mapping)

Cardiac imaging modalities (invasive vs. non-invasive)

Cardiac imaging parameters / metrics (e.g., LVESD, EF, wall thickness, LGE)

Cardiac imaging markers for cardiomyopathy

Cardiac imaging guidelines / committees

Cardiac imaging for monitoring AF burden
Cardiac catheterization / catheter-based procedures / angiocardiography / coronary angiography

Cardiac catheterization laboratory / interventional team / procedures / ICU support

Cardiac catheter ablation (including AF with HF)

Cardiac interventions / myectomy / ICD placement / surgical repairs

Cardiac device implantation / implantable electronic devices (CIED)

Cardiac device endocarditis
Cardiac function / baseline assessment / monitoring / metrics (EF, stroke volume, systolic function)

Cardiac contractility / contractility modulation (CCM)

Cardiac hemodynamics (resting and exercise)

Cardiac index

Cardiac chamber quantification / size / function / guidelines
Cardiac care / critical care / ICU outcomes / intensivist involvement

Cardiac management strategies / decision-making

Cardiac medication during pregnancy

Cardiac anticoagulation
Cardiac conduction / conduction system / conduction delay

Cardiac arrhythmias / arrhythmia risk factors / arrhythmia suppression trial (CAST / CATS)

Cardiac electrophysiology / procedures / fellowship / ambulatory rhythm monitoring
Calcium handling / Ca²⁺ mishandling / overload / signaling / sensitization / supplementation

Ca²⁺/calmodulin-dependent protein kinase II (CaMKII) activation / signaling / RyR2 hyperphosphorylation

Caffeine consumption / abstention / triggers

Cancer risk related to cardiac imaging or alcohol

CAR T-cell therapies (tisagenlecleucel, axicabtagene ciloleucel)

CABG / coronary artery bypass grafting / CABG patch trials / study identifiers

Calcineurin inhibitor therapy / elimination (e.g., cyclosporine, tacrolimus)
Cardiac chambers / chamber size / volume / structure / function

Cardiac valves / valvular pathology / valve disease / valve dysfunction / valve replacement / valve implantation / valve surgery

Cardiac myosin (S2 region, alpha-myosin)

Cardiac tissue destruction / infiltration / viral infiltrate

Cardiac morphology / phenotypic spectrum

Cardiometrics / cardiac performance / cardiac power output
Cardiac output / monitoring / augmentation / reserve / demands

Cardiac perfusion / myocardial oxygen delivery

Cardiac contractility / performance metrics

Cardiac repolarization abnormalities

Cardiac sympathetic activity

Cardiac tolerance / long-term cardiac tolerance

Cardiac rhythm / rhythm abnormalities / rhythm disorder / rhythm monitoring / rhythm restoration / rhythm conversion time

Cardiac arrhythmias / rhythm control / re-entry circuits

Cardiac rhythm management devices (pacemakers, defibrillators, CRT devices)

Cardiac pacing / physiological pacing / LV pacing / CRT / conduction-system pacing

Cardiac pacemaker / atrial leads

Cardiac resynchronization therapy (CRT / CRT-D / CRT implantation / reverse remodeling)
Cardiac troponin (cTn, cTnI, cTnT, assay, normalization)

Cardiac myosin inhibitors (e.g., mavacamten)

Cardiac pharmacokinetics (loading vs maintenance doses)
Cardiomyopathy (dilated, idiopathic, ischemic, anthracycline-induced, trastuzumab-induced, peripartum, familial, AF-induced, arrhythmia-induced, general, unresponsive)

Cardiomyopathy genes / etiology / surveillance / program

Cardiac amyloidosis / AL amyloidosis / TTR amyloidosis

Cardiac hypertrophy / remodeling / reverse remodeling / maladaptive structural changes

Cardiac shock / cardiogenic shock (classification, diagnostic criteria, management, protocols)

Cardiac tamponade

Cardiac sarcoidosis

Cardiac fibrosis

Cardiogenic limb emboli / cardioembolic events / cardioembolic stroke / cardioembolic risk / cardioembolic source

Cardiac symptoms / pulmonary-related cardiac symptoms (dyspnea, pulmonary edema)

Cardiac murmur
Cardiac surgery (open-heart, CABG, valve replacement, repair, stenting, transcatheter intervention, post-operative arrhythmias, ACHD expertise)

Cardiac procedural outcomes / surgical outcomes / operative risk

Cardiac transplant / transplantation (including bridge with mechanical assist device, muscular dystrophy, adult congenital heart disease, amyloidosis, valve regurgitation)

Cardiac catheterization / catheter-based interventions / angiocardiography / coronary angiography

Cardiopulmonary bypass (including in pregnancy)

Cardiac rehabilitation (CR) – center-based, home-based, virtual, exercise-based, cardio-oncology, post-MI/angina/SCAD, HFpEF/HFmrEF, congenital heart disease, post-aortic surgery

Cardiac rehab program / attendance / completion / access

Cardiac prevention / cardioprotective management strategies / cardioprotective exercise / cardioprotective effects (e.g., light-moderate alcohol)
Cardiac monitoring (baseline, longitudinal, intermittent, continuous, echocardiography)

Cardiac ultrasound

Cardiac stress testing / stress imaging / stress laboratory

Cardiopulmonary exercise testing (CPET, treadmill, semi-supine bicycle, ventilatory efficiency, aerobic capacity, functional capacity, exercise tolerance)

Cardiopulmonary magnetic resonance
Cardiac risk assessment / risk index / risk score / risk stratification (including HCM, pregnancy)

Cardiogenic risk in primary prevention of cardiovascular disease

Cardioimmunology / cardiogenetics / inherited cardiac disease / genetic screening
Cardiologist / ACHD cardiologist / aortic specialist / heart failure expert / maternal-fetal medicine specialist

Cardiology / cardiology fellowship / guidelines / practice / editorial work / specialist roles

Cardiac surgical care / expertise / decision-making / education
Cardiac safety / monitoring / safety assessment

Cardiac therapy adherence / cardiac therapies / cardiac toxicity

Cardiac radiation exposure

Cardiac-related pharmacology / substance-specific cardiac effects
Cardiorenal syndrome

Cardiorespiratory fitness

Cardiorespiratory training

Cardiorheumatology (cardiac involvement in systemic rheumatic disease)

Cardiotoxic anticancer therapies

Cardiotoxicity / cardiotoxicity risk stratification

Cardioselective beta-blockers

Cardiovascular drugs / pharmacotherapy / medication safety

Cardiovascular drug-drug interaction recommendations (e.g., statins)

Cardiovascular-glycemic management (GLP-1, SGLT2 agents)

Cardiovascular therapies (pharmacologic agents, device therapies)
Cardiothoracic (CT)

Cardiothoracic imaging / cardiovascular imaging / imaging modalities (TTE, CT, MRI, CMR)

Cardiothoracic magnetic resonance imaging (CMR)

Cardiothoracic surgeon / surgery / surgical specialties / surgical team

Cardiovascular catheterization / angiography / angioplasty / interventions

Cardiovascular device / implantable electronic device (CIED) / device infection

Cardiovascular procedures (general)

Cardiovascular magnetic resonance / CMR techniques / studies / imaging terms (dyssynchrony, remodeling, cone reconstruction)
Cardiovascular disease (CVD) / cardiovascular complications / risk / endpoints

Cardiovascular abnormalities / malformations / complications (e.g., Turner’s syndrome, pregnancy, HIV, vasculitis, cancer therapy)

Cardiovascular ageing

Cardiovascular collapse

Cardiovascular burden / morbidity / mortality / morbidity and mortality outcomes

Cardiovascular events / event prevention / event reduction / event risk (MI, stroke, PAD, arrhythmias, HF)

Cardiovascular outcomes / outcome metrics / outcomes research / trials

Cardiovascular phenotype / phenotyping

Cardiovascular stroke / cardio-embolic stroke

Cardiogenic shock / cardio-gic shock

Cardioversion (electrical, pharmacologic, direct-current, safety, energy delivery, LA stunning)

Cardioverter-defibrillator therapy
Cardiovascular risk / risk assessment / risk prediction / risk profile / risk factor / risk reduction / risk management / risk stratification / risk amplifiers

Cardiovascular risk scores (Framingham, CHA₂DS₂-VASc, CHARGE-AF)

Cardiovascular risk factors (BP, lipids, BMI, diabetes, smoking, alcohol, second-hand smoke, hyperlipidemia, dyslipidemia, comorbidities)

Cardiovascular risk in smokers / e-cigarette users / pregnancy / autoimmune disorders

Cardiovascular disease prevention / primary & secondary prevention / preventive strategies / preventive guidelines (ACC/AHA, ESC)

Cardiovascular screening / screening guidelines
Cardiovascular health / promotion / interventions / management / outcomes / equity / disparities / astronaut-specific outcomes

Cardiovascular functional class (NYHA)

Cardiovascular fitness / exercise capacity / rehabilitation (ACVPR, AHA, center-based, home-based, post-MI/SCAD/HF, cardio-oncology, pulmonary rehab)

Cardiovascular & pulmonary rehabilitation

Cardiovascular & metabolic sciences
Cardiovascular specialist / specialists / nurses / team-based care

Cardiovascular institute / research group / research institution / research network

Cardiovascular fellowship / fellowship program / interventional fellows

Cardiovascular anesthesiologist / anesthesiologists
Cardiovascular outcomes research / quality and outcomes research

Cardiovascular policy (e.g., smoke-free workplace)

Cardiovascular research / research network / research programs
Cardiovascular system / systems (including company names)

Cardiovascular or CV / CVD (general domain)

Cardiovascular endpoints

Cardiovascular operations / service line / services / status

Cardiovascular safety / safety assessment / toxicity

Cardiovascular effects (cocaine, ENDS, marijuana, opioids, second-hand smoke)

Cardiovascular considerations (pregnancy, HIV, aortic care)

Cardiovascular event metrics / future ASCVD events
Cardio-Obstetrics

Cardio-Obstetrics Care Team

Cardio-Oncology

Cancer Therapy–Related Cardiac Disease

Cardio-Protective Diet

Cardiopulmonary Exercise Testing (CPET)

Cardio-Renal Considerations

Cardiorespiratory Fitness

Cardiothoracic Surgery in Hypertrophic Cardiomyopathy

Cardiovascular Disease

Cardiovascular Disease Epidemiology

Cardiovascular Disease Prevention

Cardiovascular Risk Stratification

Cardiovascular Events

Cardiovascular Outcomes

Cardiovascular Mortality

Cardiovascular Rehabilitation

Cardiovascular Surgery Indications

Cardiovascular Clinical Trials

Care Coordination

Care Settings (Inpatient / Outpatient)

Caregiver Support

Carotid Artery Disease

Carotid Atherosclerosis

Carotid Revascularization

Carpal Tunnel Syndrome

Carpentier–Edwards Pericardial Bioprosthesis

CARPREG II Risk Score

Carvedilol

Cascade Genetic Testing

Cascade Screening of At-Risk Relatives

Case Management

Case Volume (Center and Surgeon)

Cardiac Arrest Study Hamburg (CASH Trial)

Cardiac Arrhythmia Suppression Trial (CAST)

CAST-II Trial

CASTLE-AF Trial

Catecholamine Spillover

Cardiac Catheterization Laboratory Activation

Catheter Ablation

Catheter Ablation for Atrial Fibrillation

Catheter Ablation for Ventricular Arrhythmias

Cavotricuspid Isthmus Ablation

Catheter-Based Cardiac Interventions

Catheter-Based Revascularization

Catheter-Directed Thrombolysis

Catheter-Based Mechanical Thrombectomy

Catheter-Based Therapies

Catheter-Derived Imaging

Cavopulmonary Shunt

Causative Factors of Aortic Aneurysm

Chronic Coronary Disease (CCD)

Congenitally Corrected Transposition of the Great Arteries (CCTGA)

CD4⁺ T Cells

T-Cell Exhaustion Marker (CD69)

Centers for Disease Control and Prevention (CDC)

Clinical Decision Pathway (CDP)

Clinical Decision Support for Atrial Fibrillation (CDS-AF Tool)

Celecoxib
Celiac Artery

Visceral Artery Involvement in Aortic Aneurysm (celiac, SMA, renal)

Celiac Artery Coverage

Centerline Measurement Technique

Central Aortic Cannulation

Central Cannulation (Aortic Arch)

Cerebrospinal Fluid Drainage

Cerebrospinal Fluid Pressure Management

Chronic Aortic Dissection

Chronic Type B Aortic Dissection

Cervical Artery Abnormalities

Chronic Limb-Threatening Ischemia (CLTI)

Chronic Total Occlusion (CTO)
Cerebrovascular Disease

Cerebrovascular Events (Stroke)

Cerebral Ischemia

Cerebral Hemorrhage

Cerebral Infarction

Cerebral Embolism / Thromboembolism

Cerebral Aneurysm

Cerebral Malperfusion

Cerebral Perfusion

Cerebral Protection Strategies

Central Nervous System Event

Cerebral Amyloid Angiopathy

Cerebral Abscess

Cerebrovascular Complications
Central Obesity

Central Adiposity

Cholesterol

Dyslipidemia

Cholesterol Management

Cholesterol-Lowering Therapy

Cholesterol Clinical Practice Guidelines

Chronic Disease Risk Behaviors

Chronic Disease Management

Childhood obesity
Central Sleep Apnea

Chronic Lung Disease

Chronic Obstructive Pulmonary Disease (COPD)

Cardiorespiratory Fitness

Chest Radiography

Chest X-Ray

Chest Tube Output
Cardiac Chamber Size and Geometry

Cardiac Chamber Quantification

Chamber Dilation / Enlargement

Chamber Function

Chronotropic Incompetence

Chronic Tachycardia

Chordal Rupture

Chordal-Sparing Mitral Valve Replacement
Chronic Aortic Regurgitation

Chronic Severe Aortic Regurgitation

Chronic Mitral Regurgitation

Chronic Primary Mitral Regurgitation

Chronic Secondary Mitral Regurgitation

Chronic Pulmonary Regurgitation
Chronic Coronary Disease (CCD / CAD)

Chronic Coronary Syndrome (CCS)

Chronic Stable Angina

Chronic Myocardial Infarction

Chronic Stable Ischemic Heart Disease

Chronic Management After SCAD

Chronic Symptomatic Peripheral Artery Disease
Chronic Heart Failure

Chronic Congestive Heart Failure

Chronic Symptomatic Heart Failure

Chronic Right Ventricular Pacing
Chemotherapy-Related Cardiotoxicity

Chemotherapy-Induced Arrhythmias

Chemotherapy-Related Cardiac Monitoring

Chest Radiation Therapy

Cell and Gene Therapy

CAR-T Cell Therapy

Prothrombotic States Associated with Chemotherapy
Chronic Atrial Fibrillation

CHA₂DS₂-VASc Score

CHADS₂ Score

Stroke Risk Stratification in Atrial Fibrillation

Chronic Anticoagulation

Chronic Embolism Risk
Congenital Heart Disease

Chromosomal Abnormalities

22q11 Deletion Syndrome

Chronic Cyanosis

Childhood / Pediatric Heart Disease
Chronic Kidney Disease (CKD)

Chronic Hypertension

Chronic Hypoxemia

Chronic Inflammatory Disease

Chronic Inflammatory Cardiomyopathy
Cesarean Delivery in Cardiac or Aortic Disease

Cesarean Section

CARPREG II Risk Score
Chest Pain

Chest Pain Evaluation

Chest Pain Centers

Cessation Counseling

Central Venous Access

Central Venous Pressure

Central Venous Oxygen Saturation

Cephalic Vein

Catheter-Related Infection

Centers for Medicare & Medicaid Services (CMS)
Cephalosporins

Chelation Therapy

Celecoxib

Cholesterol Treatment Trialists (CTT) Collaboration

Children’s Heart Foundation

Center for Heart Disease Prevention
CIBIS Trials (Bisoprolol in Heart Failure)

Canadian Implantable Defibrillator Studies (CIDS)

CLARITY–TIMI 28 Trial

CLEAR Outcomes Trial

COACH Trial

COACT Trial

COAPT Trial

COMMIT Trial

COMPASS Trial

COLCOT Trial

COMMANDER-HF Trial

Clinical Trials / Randomized Controlled Trials

Clinical Registries and Registry Outcomes
Cardiac Intensive Care Unit (CICU)

Collaborative / Team-Based Cardiovascular Care

Clinical Care Pathways

Clinical Surveillance Programs

Clinical Practice Settings

Community-Based Cardiovascular Care
Cardiac Magnetic Resonance Imaging (CMR)

Cine Cardiac Imaging

Cine CT Imaging

Color Doppler Imaging

Color Flow Doppler

CMR Risk Stratification

CMR Tissue Mapping

CMR-Measured Regurgitant Fraction
Circulating Biomarkers

Cardiac Biomarkers

Creatine Kinase-MB (CK-MB)

Coagulation Monitoring (INR)
Class I Antiarrhythmic Drugs

Class IA Antiarrhythmics

Class IB Antiarrhythmics

Class IC Antiarrhythmics

Class III Antiarrhythmic Drugs
Clinical Atrial Fibrillation

Clinically Evident Atrial Fibrillation

Atrial Flutter (Clockwise)

Clinical Cardiac Electrophysiology

Clinical Arrhythmias
Cardiomyopathy

Cocaine-Associated Cardiomyopathy

Clinical Decompensation

Clinical Congestion

Clinical Stability

Clinical Phenotyping of Cardiomyopathy

Clinical Heart Failure Assessment
Clinical Atherosclerotic Cardiovascular Disease (ASCVD)

Peripheral Artery Disease (PAD)

Claudication

Collateral Circulation

Collateral Vessel Formation

Chronic Kidney Disease Stage 3–4
Cleft Mitral Valve

Mitral Commissurotomy

Closed Mitral Commissurotomy

Commissural Calcification

Commissural Fusion

Coaptation Length

Common Atrioventricular Valve
Coarctation of the Aorta

Hemodynamically Significant Coarctation

Congenital Heart Disease
Coagulation Cascade

Coagulopathy

Thrombosis

Clopidogrel Therapy

Dual Antiplatelet Therapy (Aspirin + Clopidogrel)

Anticoagulation Strategies
Bisoprolol

Cilostazol

Clarithromycin

Clevidipine

Clonidine

Colchicine Therapy

Coenzyme Q10
Clinical Assessment

Clinical Evaluation

Clinical Presentation

Clinical Outcomes

Major Adverse Cardiovascular Events (MACE)

Quality of Life Outcomes

Mortality and Morbidity Outcomes
Clinical Genetics

ClinGen (Clinical Genome Resource)

Clinically Actionable Genetic Variants

Clinical Utility of Genetic Testing
Cigarette Smoking

Cocaine Use

Climate Change–Related Cardiovascular Risk

Community Health Workers

Community-Based Exercise Therapy

Social and Environmental Cardiovascular Risk Factors
Cognitive Impairment

Neurocognitive Dysfunction

Cognitive Disorders
Combined Heart–Liver Transplantation

Advanced Heart Failure Therapies
COMPASS Trial

Competing Cardiovascular Risks / Outcomes

Competitive Sports Participation in Cardiovascular Disease

Complete Atrioventricular Septal Defect (Complete AVSD)

Complete Heart Block

Complete Revascularization

Complex Coronary Artery Disease

Complex Congenital Heart Disease

Complex Coronary / Structural Lesions

Complicated Aortic Syndromes

Myocarditis (Complicated)

Clinical Complications

Post-Procedural Complications

Aortic Disease Complications

Pulmonary Artery Intervention Complications

Composite Cardiovascular Outcomes

Composite Clinical Endpoints

Composite Bypass / Valve–Graft Conduits

Genetic Compound or Double Mutations

Comprehensive Atrial Fibrillation Care

Comprehensive ASCVD Prevention

Comprehensive Cardiovascular Care

Specialized Cardiovascular Centers

Comprehensive Cardiac Imaging

Compression Stockings

Computed Tomography (CT) Imaging

Computed Tomographic Angiography (CTA)

Coronary CT Angiography (CCTA)

Concentric Left Ventricular Hypertrophy

Pregnancy and Conception in Aortic Disease

Concomitant Cardiac Conditions

Conduction System Disease

Conduction System Pacing

Cardiac Conduits and Grafts

Cone Procedure for Tricuspid Valve Repair

Statistical Confidence Intervals

Confirmatory Diagnostic Evaluation

Congenital Cardiovascular Abnormalities

Congenital Aortic Valve Disease

Congenital Heart Disease (CHD / ACHD)

Congenital Mitral Valve Disease

Congenitally Corrected Transposition of the Great Arteries (CCTGA)

Congestion and Volume Overload

Congestive Heart Failure / Heart Failure

Congestive Hepatopathy

Connective Tissue Disorders

Connexins and Cardiac Gap Junctions

Conotruncal Defects

Clinical Consensus Guidelines

Conservative Management Strategies

Constrictive Pericarditis

Cardiovascular Consultative Services

Consumer ECG Devices

Contained Aortic Rupture
Contemporary Cardiovascular Management Strategies

Conventional Treatment Approaches

Continuous Patient Education

Continuous Disease Monitoring

Contraindications in Cardiovascular Therapy

Reproductive Planning and Contraception in Cardiovascular Disease
Continuous Anticoagulation Therapy

Bridging / Replacement Anticoagulation Strategies

Continuous Intravenous Inotropic Therapy

Diuretic Administration Strategies (Continuous vs Bolus)

Conventional Disease-Modifying Antirheumatic Drugs (csDMARDs)

Corticosteroid Therapy
Continuous ECG Monitoring

Continuous Rhythm Monitoring

Implantable and Wearable Cardiac Monitors

Continuous ST-Segment Monitoring

Conventional Cardiac Pacing

Continuous-Flow Ventricular Assist Devices (LVADs)
Continuous Positive Airway Pressure (CPAP) Therapy
Cardiac Contractility

Contractile Reserve

Hemodynamic Assessment

Coronary Hemodynamics

Coronary Flow Reserve (CFR)
Contrast-Enhanced Cardiovascular Imaging

Coronary Angiography (Invasive and CT-Based)

Coronary Computed Tomography Angiography (CCTA / CTA)

Contrast-Associated Acute Kidney Injury

Contrast-Induced Nephropathy (CIN / CI-AKI)

Contrast Risk Stratification (Mehran Score)
Continuous-Wave Doppler Ultrasound
Atrial Fibrillation Conversion to Sinus Rhythm

Conventional Catheter Ablation

Continuous Rhythm Assessment
Cor Pulmonale

Chronic Obstructive Pulmonary Disease (COPD) as Cardiovascular Comorbidity
Cor Triatriatum

Congenital Coronary Artery Abnormalities

Congenital Cardiac Anatomy Variants

Congenital Coarctation Repair Residual Gradient
Coronary Artery Anatomy

Coronary Artery Anomalies

Coronary Atherosclerosis

Coronary Artery Disease (CAD / Ischemic Heart Disease)

Coronary Microvascular Dysfunction

Coronary Vasomotor Disorders

Coronary Thrombosis

Coronary Dissection

Coronary Fistulas

Coronary Compression Syndromes
Coronary Physiology Assessment (FFR / CT-FFR)

Coronary Plaque Assessment

Coronary Calcium Scoring (CAC)

Coronary Risk Stratification

Coronary Imaging Follow-Up
Percutaneous Coronary Intervention (PCI)

Coronary Stent Implantation

Coronary Revascularization

Coronary Revascularization Strategy Selection

Coronary Reintervention
Coronary Artery Bypass Grafting (CABG)

CABG Indications and Outcomes

CABG vs PCI Decision-Making

CABG-Associated Complications

CABG in Cardiogenic Shock
Coronary Ischemia

Acute Coronary Syndromes

Major Adverse Coronary Events

Coronary Disease Clinical Outcomes
Coronary Risk Factors

Coronary Risk Modification

Coronary Risk Scores

Secondary Prevention of Coronary Disease
Copy-Number Variants and De Novo Mutations
COVID-19 (Coronavirus Disease 2019)
Healthcare Cost

Cost of Care

Cost Estimation

Cost and Value Considerations in Cardiovascular Care

Cost-Effectiveness

Cost-Effectiveness Analysis

Cost-Utility Analysis

Incremental Cost-Effectiveness Ratio (ICER)

Quality-Adjusted Life Years (QALYs)

Cost-Effective Prevention Strategies

Cost-Effective Screening

Cost-Effective Medical Management

Cost-Effectiveness of Cardiovascular Therapies

Cost-Effectiveness of Cardiovascular Devices

Cost-Effectiveness of Aortic Screening and Intervention

Cost-Effectiveness of Atrial Fibrillation Treatment

Cost-Effectiveness of Mechanical Circulatory Support

Cost-Related Medication Nonadherence

Cost-Saving Healthcare Strategies

Value Assessment in Cardiovascular Guidelines

Cost–Value Analysis of Cardiovascular Interventions
ACE Inhibitor–Induced Cough

Cyclooxygenase (COX) Inhibitors

COX-2 Selective Inhibitors

Cyclophosphamide Therapy

Cytokinetics
Covered Stents

Endovascular Stent Exclusion

Customized Grafts

Crawford Classification of Thoracoabdominal Aortic Aneurysm

Cross-Sectional Aortic Area–to–Height Ratio

Aortic Disease Management in Pregnancy
COVID-19 (SARS-CoV-2 Infection)

COVID-19 Cardiovascular Complications

COVID-19–Related Myocardial Injury

COVID-19–Associated Myocarditis

COVID-19–Associated Thrombosis

COVID-19 Vaccination

COVID-19 Vaccination for Cardiovascular Risk Reduction
Atrial Flutter (Typical and Atypical)

Reentrant Atrial Flutter Circuits

Cavotricuspid Isthmus–Dependent Atrial Flutter

Atrial Fibrillation in Critical Illness

Maze Procedure

Cryoablation

Cryoballoon Ablation

Pulmonary Vein Isolation

Ablation in Adult Congenital Heart Disease

Cardiac Resynchronization Therapy (CRT)

CRT with Defibrillator (CRT-D)

CRT with Pacemaker (CRT-P)

CRT Cost-Effectiveness
Cardiopulmonary Exercise Testing (CPET)

Cardiac Rehabilitation

Functional Capacity Assessment
Serum Creatinine

Creatinine Clearance

Renal Function–Guided Drug Dosing

Cystatin C

Creatine Kinase

Creatine Kinase–MB

Cardiac Troponin
Critical Illness

Critical Care Cardiology

Critical Care Atrial Fibrillation

Critical Limb Ischemia

Critical Limb-Threatening Ischemia (CLTI)

CLTI Management Guidelines

Critical Time-to-Treatment Metrics

Cross-Clamp Time

Cross-Clamp Use
Cross-Sectional Imaging

Computed Tomography (CT)

CT Angiography

4D CT Imaging

CT Aortic Valve Calcium Scoring

Multimodality Aortic Imaging

Cumulative Radiation Exposure
Culprit Lesion

Culprit Vessel

Culprit-Only Percutaneous Coronary Intervention

Multivessel vs Culprit-Only Revascularization

Cardiogenic Shock Revascularization Strategy

Cryptogenic Stroke
Cardiac Sarcoidosis

Culture-Negative Endocarditis

C-Reactive Protein as Cardiovascular Risk Marker
Cytochrome P450 Enzyme System

CYP2C19 Polymorphisms

CYP-Mediated Drug Metabolism

Pharmacogenomics in Cardiovascular Therapy
Current Tobacco Smoking

Cultural Humility in Healthcare

Customized Footwear for Ischemia Prevention
Composite Cardiovascular Outcomes

Cumulative Survival

Crossover Rate in Clinical Trials

Risk Discrimination Metrics (C-Index)

Current Cardiovascular Literature

Cardiovascular Disease (CVD)

Cardiovascular Mortality

Cardiovascular Events
Cyanosis

Cyanotic Congenital Heart Disease

Right-to-Left Shunting

Cyanosis-Associated Exercise Limitation

Coronary Artery Disease (CAD)

De Novo Coronary Lesions

Degenerative Coronary Disease

Demand-Induced Myocardial Infarction (Type 2 MI)

Sudden Cardiac Death (Ischemic Etiology)

Coronary Atherosclerosis Progression

Coronary Thrombosis

Coronary Plaque Instability
Acute Myocardial Infarction

Post–Myocardial Infarction Management

Delayed Coronary Angiography

Delayed Invasive Strategy in ACS

Mechanical Complications of MI

Post-Infarction Ventricular Septal Rupture (VSR)
Coronary Angiography

Percutaneous Coronary Intervention (PCI)

Coronary Artery Bypass Grafting (CABG)

Dual Antiplatelet Therapy (DAPT)

DAPT Duration After CABG

DAPT Risk Stratification

Dual Antithrombotic Therapy (DAT)

Delayed Revascularization

Debranching (Hybrid Coronary/Aortic Context)

Deep Hypothermic Circulatory Arrest (Surgical Support Technique)
Anticoagulation in Coronary Disease

Direct Thrombin Inhibitors

Dabigatran Therapy

Antiplatelet Therapy Strategies

Bleeding vs Ischemic Risk Balance
Coronary Imaging

Delayed-Enhancement Cardiac Magnetic Resonance (Ischemic Scar Imaging)

Delayed Hyperenhancement (Myocardial Infarction)

High-Sensitivity Cardiac Troponin Dynamics

Delta Troponin Change

Dense Continuous-Wave Doppler Signal (Coronary Hemodynamics Context)
All-Cause Mortality

Cardiovascular Mortality

Sudden Cardiac Arrest

DANISH Trial (Ischemic Context Excluded; SCD Comparator)

DINAMIT Trial

DECOPI Trial

Deferred Revascularization (FFR-Guided Strategy)
Ischemic Risk Stratification

Coronary Decision Aids

Shared Decision-Making in Coronary Revascularization

Timing of Intervention in Acute Coronary Syndromes
Infective Endocarditis With Coronary Complications

Dental-Related Bacteremia (Coronary Risk in IE Context)
Depression

Depression as a cardiovascular risk factor

Depression as a cardiovascular comorbidity

Depression as a risk amplifier

Depression impacting heart failure prognosis

Depression and heart failure outcomes

Depression in cardiac populations (HF, ACHD, aortic disease)

Depression, anxiety, and stress as cardiovascular risk factors
Drug-eluting stents (DES)

De-escalation of dual antiplatelet therapy (DAPT)

P2Y12 inhibitor de-escalation strategies
Descending aorta

Descending thoracic aorta

Descending thoracic aortic aneurysm

Descending aortic aneurysm

Descending aortic dilation

Descending aortic replacement
Desmoplakin (DSP)

Desmoplakin gene variants / mutations

Desmoplakin cardiomyopathy

Desmosomal gene mutations
Destination therapy

Destination therapy strategy
Determinants of myocardial infarction onset

Supplemental oxygen therapy in acute MI (DETO2X-AMI trial)
Cardiac devices

Cardiac device therapy

Device-based cardiac therapy

Permanent cardiac devices
Cardiac device implantation

Device placement and selection

Device indications

Device management (pacemakers, ICDs, CRT)

Device surgery

Device bridging to transplant
Device-related complications

Device infection

Device-related endocarditis

Device erosion

Device migration

Device-related thrombosis

Device-related thrombus

Lead-related tricuspid valve dysfunction

Device extraction
Device-detected atrial fibrillation

Device-detected subclinical atrial fibrillation

Device-detected atrial arrhythmias

Device-detected atrial high-rate episodes (AHRE)

Device-detected arrhythmia duration
Dextro-transposition of the great arteries (D-TGA)

D-TGA after atrial switch (Mustard/Senning)

D-TGA after arterial switch operation

D-TGA after Rastelli operation
Exercise-induced desaturation
Dermatologic toxicity
Diabetes mellitus

Type 1 diabetes mellitus

Type 2 diabetes mellitus (T2DM)

Diabetes as a cardiovascular risk factor

Diabetes as a cardiovascular risk modifier

Diabetes as a comorbidity in cardiovascular disease

Diabetes in coronary artery disease

Diabetes in heart failure

Diabetes in peripheral artery disease (PAD)

Poor glycemic control as a modifiable cardiovascular risk factor

Diabetes-related ASCVD risk

Diabetes-related vascular disease

Diabetic coronary artery disease

Diabetes-associated microvascular complications

Diabetic neuropathy

Diabetic retinopathy

Diabetic foot ulcer
Diabetes management

Diabetes care standards

Diabetes management as cardiovascular risk reduction

Pharmacologic diabetes management

SGLT2 inhibitors

GLP-1 receptor agonists

DPP-4 inhibitors

Diabetes-related cardiovascular prevention
Diagnosis

Diagnostic evaluation

Diagnostic criteria

Diagnostic algorithms

Diagnostic accuracy

Diagnostic sensitivity and specificity

Diagnostic thresholds

Diagnostic testing (cardiovascular)

Diagnostic imaging

Diagnostic laboratory testing

Diagnostic monitoring

Diagnostic risk assessment models
Diagnosis and management of atrial fibrillation

Diagnosis and management of heart failure

Diagnosis and management of coronary artery disease

Diagnosis of peripheral artery disease

Diagnosis of chest pain

Diagnosis of infective endocarditis

Diagnostic workup for cryptogenic stroke
Aortic diameter

Aortic diameter thresholds for intervention

Diffuse aortic dilation

Ascending aortic dilation

Aortitis

Diffuse atherosclerotic disease
Diastolic blood pressure

Diastolic function

Diastolic dysfunction

Heart failure with preserved ejection fraction (HFpEF)

Diastolic filling parameters

Diastolic flow abnormalities
Diet as a cardiovascular risk factor

Heart-healthy diet

Dietary modification

Diet quality

Dietary patterns (e.g., Mediterranean diet)

Dietary sodium intake

Dietary sodium restriction

Dietary potassium intake

Dietary fat intake

Dietary fiber intake

Dietary supplementation

Nutrition counseling / dietitian involvement
Digital health

Digital health interventions

Digital health monitoring

Digital health platforms and tools

Digital care transformation
Digoxin (digitalis)

Digoxin toxicity

Calcium channel blockers

Dihydropyridine calcium channel blockers

Nondihydropyridine calcium channel blockers

Diltiazem

Nonsteroidal anti-inflammatory drugs (e.g., diclofenac)
Dilated cardiomyopathy (DCM)

Genetic dilated cardiomyopathy

Dilated-phase hypertrophic cardiomyopathy

Diffuse myocardial fibrosis
Direct oral anticoagulants (DOACs)

Direct thrombin inhibitors

Factor Xa inhibitors

DOAC pharmacokinetics and pharmacodynamics

Non–vitamin K oral anticoagulants
Direct current cardioversion

Electrical cardioversion

Direct-current ablation
Heart failure diagnosis

Heart failure disease staging

Disease progression

Disease management programs

Disease burden

Disease-related morbidity and mortality

Discharge planning and education

Discharge risk stratification
Discrete coronary lesions

Diffuse coronary lesions

Angiosomal revascularization strategies

Pulmonary artery dilation

Chamber dilation (RA, RV, LV)
DIG trial (Digitalis Investigation Group)

Diamond–Forrester probability model

Discharge risk prediction models
Disease-modifying antirheumatic drugs (DMARDs)

Transthyretin amyloidosis disease-modifying therapies

TTR stabilizers

TTR silencers

TTR disruptors
Disopyramide

Dofetilide

Dronedarone

Dobutamine

Dopamine

Doxazosin

Dulaglutide

Docosahexaenoic acid (DHA)
Healthcare disparities

Disparities in cardiovascular care and outcomes

Access to care

Travel distance to care
Dispersion of repolarization

Dormant conduction

Drug-induced arrhythmias

Drug-induced torsades de pointes

Downstream consequences of atrial fibrillation
Functional mitral regurgitation

Disproportionate functional mitral regurgitation

Double-orifice mitral valve

Double valve replacement

Aortic dissection

Dissecting aneurysm

Aortic dissection at small diameter

Aortic dissection flap

Aortic intimal flap

Distal aorta

Distal ascending aorta

Distal aortic arch

Distal aortic enlargement

Distal aortic extension

Distribution of aortic size

Double-density sign of aortic dissection
Distal pulmonary artery

Distal subclavian artery

Dominant vertebral artery

Distal branch perfusion

Distal embolization

Distal flow reversal

Dorsalis pedis pulse
Distal convoluted tubule
Diuretic therapy

Loop diuretics

Diuretic dose escalation

Diuretic resistance

Diuretic synergism

Diuretic-refractory congestion

Decongestion strategies

Ultrafiltration / aquapheresis
Dizziness

Distention
Drug-coated balloon angioplasty

Drug-eluting stents

Dual antiplatelet therapy (DAPT)

DAPT duration

Dual antithrombotic therapy

Dual therapy (oral anticoagulant + antiplatelet)
Direct oral anticoagulants (DOACs)

Dose-adjusted anticoagulation

Low-molecular-weight heparin

Unfractionated heparin

Warfarin
Doppler echocardiography

Doppler ultrasound

Continuous-wave Doppler

Color flow Doppler

Doppler-derived gradients

Doppler-based valve area

Doppler hemodynamics

Duplex ultrasound

Duplex ultrasound surveillance
Dobutamine stress echocardiography

Dobutamine challenge
Double-chambered right ventricle (DCRV)

Double-outlet right ventricle (DORV)

Double-switch operation

Ductus arteriosus

Patent ductus arteriosus

Down syndrome (trisomy 21)
Dual-chamber pacing

Dual-chamber implantable cardioverter-defibrillator

Dual-coil ICD leads

Dual-site ventricular pacing
Donor heart allocation

Heart allocation policy

Donor–recipient size matching

Dual-organ transplantation
Door-to-balloon time

Door-in–door-out time
Drug therapy

Drug classification

Drug interactions

Drug–drug interactions

Cytochrome P450–mediated interactions

P-glycoprotein interactions

Drug-induced heart failure

Drug-induced lung toxicity

Drug tolerability

Dose adjustment

Dose–response relationship
Dressler syndrome
Drug-use–associated endocarditis

Duke criteria
Dual-energy X-ray absorptiometry (DXA)
Duke Treadmill Score
Durable left ventricular assist device (LVAD)

Durable mechanical circulatory support (MCS)

Durable MCS for LV or biventricular support

Durable MCS / destination therapy

Durable prosthetic valves (TAVI & surgical)

Durability of repair or replacement

Durability beyond 5–6 years

Durable LVAD or transplant pathways
Duration of atrial fibrillation / AHRE

Dynamic intraventricular obstruction

Dynamic left ventricular (LV) obstruction

Dynamic LV outflow tract (LVOT) gradient / obstruction

Dynamic LVOTO detection and quantification

Dynamic obstruction

Dynamic ST-segment changes
Dynamic resistance exercise
Dyskinesia

Dyskinetic area
Dyslipidemia

Dyslipidemia management

Hyperlipidemia / high cholesterol / triglycerides / LDL-C / HDL-C
Dysmorphic features

Dysplastic pulmonary valve cusps
Dysphagia

Dysphagia aortica

Dyspnea / shortness of breath

Dyspnea on exertion

Paroxysmal dyspnea

Dyspnea from tracheal compression or heart failure
D-dimer

D-dimer threshold (<500 ng/ml)

D-sotalol
Dextro-transposition of the great arteries (D-TGA)
ECG (electrocardiogram / 12-lead ECG)

ECG algorithm (R'' wave in V1 & terminal QRS vector in aVF)

ECG conduction and repolarization abnormalities

ECG findings (PR-segment depression, concave ST elevation, dynamic T-wave changes)

ECG interpretation criteria (ST depression, ST elevation, T-wave changes)

ECG lead placement for posterior ischemia

ECG monitoring / serial monitoring for nondiagnostic STEMI

ECG-gated acquisition

Echocardiography / echocardiogram (echo)

Echocardiography (2D, 3D, Doppler, M-mode, strain imaging, TEE, TTE)

Echocardiography (cardiac structure & function assessment)

Echocardiography (screening modality, serial imaging, exercise echo)

Echocardiographic assessment (2D, 3D, Doppler)

Echocardiographic assessment of obstruction severity / valve stenosis

Echocardiographic diastolic parameters

Echocardiographic doppler assessment

Echocardiographic evaluation / features / imaging / indices

Echocardiographic left atrial diameter

Echocardiographic measures (velocity, pressure gradients)

Echocardiographic predictors of outcome

Echocardiographic quantification / quantitative assessment of valve disease

Echocardiographic screening in first-degree relatives

Echocardiographic sensitivity / specificity

Echocardiographic strain imaging

Echo-based assessment of valve function
Early (<1 year) vs late (>1 year) aspirin initiation

Early (<2 years) vs late (>2 years) statin initiation

Early advance notification to PCI-capable hospital

Early age of disease onset

Early aggressive invasive intervention for AF (early-AF)

Early aldosterone blockade

Early and late survival after valve replacement

Early anticoagulation strategies (short-term, long-term)

Early aortic valve replacement

Early change to oral antibiotic therapy for stable IE

Early childhood (0–12 years) CHD care

Early childhood cognitive and sensory impairments (associated with phenocopies)

Early clinical course

Early corrective surgery

Early death reduction

Early detection of cardiomyopathy

Early detection of subclinical myocardial injury

Early developmental outcome in single-ventricle reconstruction

Early discharge after PCI / angioplasty

Early discharge strategy

Early eplerenone therapy

Early follow-up (within 7 days of discharge)

Early follow-up and lipid testing

Early graft infection (≤3 months)

Early initiation of oral beta-blocker therapy

Early intervention / invasive strategy / surgical intervention

Early invasive vs conservative strategy

Early markers of myocardial dysfunction

Early menopause

Early onset sporadic TAD

Early postoperative atrial fibrillation

Early postoperative complications

Early post-discharge follow-up

Early post-MI period

Early predictors of poor outcome after cardiac arrest (e.g., neurological recovery)

Early presenters (≤3 hours after symptom onset)

Early repair strategy

Early reperfusion / revascularization strategy

Early repolarization pattern

Early rhythm control / rhythm-control therapy in atrial fibrillation

Early satiety

Early surgery / surgical intervention (including severe aortic stenosis, NYHA II, post-MI)
Early thrombosis / thrombotic events

Early transfer to specialized center

Early vs delayed coronary angiography

Early vs staged PCI in cardiogenic shock

Early VHD

Early-ACS trial

Early-age percutaneous balloon dilatation

Early-onset stroke

Early-stage HCM biomarkers
EAST-AFNET 4 trial / study

ECLS-SHOCK trial

ECMO-CS trial / randomized clinical trial

EDACS (Emergency Department Assessment of Chest Pain Score)
Ebstein anomaly / Ebstein’s anomaly

Eccentric hypertrophy
Ejection fraction (EF / LVEF / RV / LV)

EF <50 % / EF ≤40 %

EF assessment / measurement / improvement / recovery

E/e′ ratio (diastolic function parameter)

Effective refractory period (ERP)
Effective regurgitant area / orifice (ERO / EROA, including ≥0.40 cm²)

Effective orifice area
eGFR (estimated glomerular filtration rate)

eGFR <15 ml/min/1.73 m²
Ehlers-Danlos syndrome (vascular type)

Ectopia lentis (clinical sign of Marfan)
Eggs
Economic analysis of heart failure treatments

Economic evaluation of PCI vs medical therapy

Economic stability / financial strain

Economic value (intermediate, therapy, cost per QALY, ICER)

Economic value indicators: cost per QALY, ICER

Economic value of CardioMEMS / cardiovascular therapies
Educational interventions / training for providers or patients

Educational status

Electronic health record (EHR)
Elective aortic root replacement

Elective ascending aortic replacement

Elective CABG

Elective non-cardiac surgery

Elective repair / elective surgery

Elective thoracic aortic repair
Electrocardiogram (ECG / EKG / 12-lead ECG)

ECG interpretation / monitoring / follow-up

ECG changes (ST-segment elevation, ischemia, infarction)

ECG QRS duration, fragmentation, voltage

ECG-gated imaging / coronary CT angiography

Electrocardiographic abnormalities (arrhythmias, AV block, irregular R-R, absent P waves, fibrillatory waves)

Electrocardiographic biomarkers

Electrocardiographic left ventricular hypertrophy

Electrocardiographic tracing interpretation

Electrocardiography / electrocardiographic imaging of cardiac structures

Electrocardiography implied by diagnostic context
Electrical cardioversion / direct-current cardioversion

Electrical dyssynchrony / fractionation / instability / remodeling

Electrical posterior box isolation

Electromechanical atrial function / dissociation

Electrophysiology (EP) / electrophysiologic interventions / procedures / evaluation

Electrophysiology ablation / endocardial ablation / catheter ablation

Electrophysiologic studies (EPS) / programmed ventricular stimulation / inducibility testing

Electrophysiologic / electrophysiological remodeling and structural remodeling of the atria

Electrophysiologic determinants of conversion efficacy

Electrophysiologist
Electrode vector / electrode vector orientation (anterior-posterior, anterior-lateral)

Electrogenic action of the sodium-calcium exchanger

Electrogram frequency analysis
Electrolyte abnormalities / balance / management

Electrolyte monitoring (general, in AF, in diuretic therapy)

Electrolytes monitoring

Endocrine / metabolic conditions (diabetes, obesity, acromegaly, pheochromocytoma)

Endocrine therapy / endocrine toxicity (thyroid)
Electronic health record (EHR / EMR / integration, cardiovascular assessment)

Electronic clinical decision support systems

Electronic consults

Electronic point-of-care reminders (for GDMT)
Electronic cigarettes / e-cigarettes / vaping / electronic nicotine delivery systems (ENDS)

Electronic cigarette effects / cardiovascular risk
Emergency department (ED) / ED management / triage / visits / length of stay

Emergency medical services (EMS) / transport / personnel (paramedics)

Emergency cardiovascular care / emergency surgery / emergency aortic repair / emergency coronary angiography

Emergency revascularization / emergency invasive strategy (<2 hours from admission)

Emergency action plans for sudden cardiac arrest in sport
Emboli / embolism / embolization / embolic events (stroke, recurrent, systemic)

Embolic risk / potential / prevention / of thrombi

Embolic stroke of undetermined source
EMERGE trial

ELITE study (Evaluation of Losartan in the Elderly)

EMPA-REG outcome trial

EMPA-Preserved / EMPA-Cardio / EMPA-Reduced trial

EMPEROR-Preserved / EMPEROR-Reduced study
Endocardial imaging / involvement / leads / voltage mapping (EVM) / healing / cushion tissue

Endocardial ablation / biopsies / endomyocardial biopsy (EMB)

Endocarditis (diagnosis, classification, guidelines, prophylaxis, mortality, prosthetic valve risk)

End-to-end anastomosis

Endarterectomy (common femoral) / endarteritis

Endograft (branched, fenestrated, endovascular repair, failure, migration, fracture, stenosis, sizing)

Endografting / endovascular repair

Endoluminal aortic aneurysm repair / endoluminal revascularization

Endoleak (types I–V, early, late, proximal/distal, branch vessels, graft defects, endotension)

Endothelial function / dysfunction / injury / disruption / endothelialization / tests

Endothelin system / endothelin receptor antagonists / therapy (ERAs)
Elevated ASCVD risk / lifetime ASCVD risk

Elevated blood pressure / hypertension

Elevated BNP / NT-proBNP / natriuretic peptides

Elevated cardiovascular biomarkers

Elevated ESR >50 mm/h

Elevated filling pressures / right heart pressure

Elevated glucose / transaminases / liver-function tests

Elevated triglyceride levels

Elevated high-sensitivity CRP (hs-CRP)

Elevated pre-therapy troponin ≥14 ng/L (>0.07 ng/mL)

Elevated heart rate / jugular venous pressure (JVP)

Elevated white-blood-cell count

Elevated-risk non-cardiac surgery
Endovascular procedures / interventions / therapy

Endovascular repair (EVAR / TEVAR / thoracic EVAR / thoracic aortic repair / stent grafting)

Endovascular abdominal aortic aneurysm repair (EVAR / AAA repair)

Endovascular aortic repair (including stent-graft, REVAR, thoracic stent-graft)

Endovascular aneurysm repair complications / follow-up / outcomes / vs open repair

Endovascular balloon occlusion (REBOA)

Endovascular devices (balloon angioplasty, drug-coated balloon angioplasty, atherectomy, stents)

Endovascular fenestration / stenting (first strategy)

Endovascular femoropopliteal intervention

Endovascular limb revascularization / peripheral artery disease interventions

Endovascular stent graft / stent-grafting / stent-graft complications / delivery systems

Endovascular therapy for PAD, type B dissection, penetrating ulcers

Endovascular thromboembolectomy

Endovascular vs. open repair outcomes / surgical management

Endovascular approach / techniques / technology / expertise / era outcomes / management

Endovascular infection / injury
Endo-tronic / endovascular therapy
End-organ damage / dysfunction / hypoperfusion / ischemia / malperfusion / performance / perfusion

End-organ criteria (hepatic failure, renal failure, cardiac, low cardiac output, right/left ventricular dysfunction)

End-stage heart disease / heart failure / hypertrophic cardiomyopathy

End-stage kidney disease (ESKD / dialysis dependence / extreme CKD stage linked to vascular disease)

End-stage renal disease (ESRD / ESKD)

End-stage renal function (eGFR < 25 ml/min/1.73 m²)

End-diastolic pressure

End-systolic dimension (ESD)

End-systolic volume index (ESVI)
ENGAGE AF–TIMI 48 trial

ENRICHD trial

ESP-CAD trial

EVEREST trial

EUCLID trial (ticagrelor in PAD / peripheral artery disease)
Enoxaparin (low-molecular-weight heparin)

Eplerenone (EMPHASIS-HF, EPHESUS trials)

Epoprostenol therapy

Eptifibatide

Enzyme replacement therapy (e.g., agalsidase β)

Enzyme-inducing antiseizure medications

Ertugliflozin

Everolimus-eluting stents
Epicardial ablation / epicardial leads / ICD system / pacemaker leads

Epicardial coronary artery disease / spasm / obstruction / compression / fat / diameter reduction / apical site pacing / LAA clipping

Epicardial vessel / CAD assessment
Epidemiology / epidemiological studies (HF, HFrEF, HFpEF, HCM, aneurysms, moderate-to-severe VHD)

Environmental exposures / risk factors (air pollution, PM₂.₅, noise, heat waves)

Environmental factors influencing cardiomyopathy

Equity, disparities, and cost-effective long-term management / equitable care and training opportunities

Ethnic disparities / ethnically and racially diverse populations
Esophageal compression / symptoms (dysphagia) / atrial fistula / lesion / varices
Estrogen-containing contraceptives / oral contraceptives (thromboembolic risk) / estrogen-only hormone regimens

Euthyroid state / euvolemia

EPA/DHA plasma levels
Event monitor / event recording (palpitations, light-headedness)

Event-free survival

Estimated 5-year sudden cardiac death risk

Estimated glomerular filtration rate (eGFR <60 ml/min/1.73 m² / <25 ml/min/1.73 m²)

Estimated pulmonary pressures

Endurance exercise

End-of-life care

Endowed chair in cardiology
Evidence

Evidence gaps / future directions / research directions

Evidence gaps in HF management

Evidence grade / level of evidence (COR, LOE, C-LD, B-NR, C-EO, etc.)

Evidence table / guideline recommendations

Evidence-based care / guidelines / interventions / therapy / management / medicine / pharmacotherapy / methodology / methodologies / recommendations / terminology

Evidence review committee / evidence-based guideline implementation

Evidence-based risk–benefit ratio (e.g., SET in PAD)
EVM – endocardial voltage mapping
Evolocumab (PCSK9 monoclonal antibody)

Exenatide

Ezetimibe (NPC1L1 inhibitor, add-on therapy, first strategy, LDL-C lowering)

Extended DAPT / extended therapy beyond 1 year post-ACS

Extended-release niacin
Exacerbation of HFrEF

Exercise-induced cardiovascular events / ischemia / arrhythmia / LVOT gradient / mitral regurgitation / angina / dyspnea / myocarditis / hypoxemia

Exercise-limiting CVD

Exertional angina / dyspnea / leg disorders / symptoms / performance / exercise capacity
Exercise / physical activity (aerobic, resistance, modifiable risk factor, cardiovascular health)

Exercise ABI testing / treadmill ABI

Exercise adherence / compliance / counseling / rehabilitation / therapy / prescription / programs

Exercise capacity / functional capacity / assessment / decline / improvement / preservation / metrics (VO₂ max) / testing / performance / exercise time / tolerance / pre-op / post-transplant / guidelines for CHD athletes

Exercise hemodynamics / intensity (low, moderate, high, MET values) / session duration / frequency / volume

Exercise ECG / Doppler echocardiography / echocardiography / stress echocardiography / treadmill / test / stress testing / TTE / graded exercise test (GXT)

Exercise-based cardiac rehabilitation / telerehabilitation / CR programs / therapy for CVD, PAD, aortic disease / supervised / home-based / structured / continuous / interval / resistance training / high-intensity aerobic / moderate-intensity / extreme exercise

Exercise prescription parameters (treadmill walking, 6MWT)

Exercise intolerance / limitation / restriction (including in desmosomal cardiomyopathy, Fontan, myocarditis, hypertrophic cardiomyopathy)

Exercise-related inflammation / acute cardiovascular events / exercise-induced LV pressure assessment
Extended aortic repair

Extended septal myectomy (ESM)

Extended cardiac monitoring / ECG / external cardiac monitors

Extent of late gadolinium enhancement (LGE) on CMR / extensive LGE ≥15% LV mass

Extensive LVOT calcification

Extracardiac conduit / Fontan conversion

Extracorporeal life support (ECLS) / ECMO / ventricular assist devices

Extracellular matrix expansion / remodeling / proteins / extracellular volume / fraction
Extended aortic repair

Extended septal myectomy (ESM)

Extended cardiac monitoring / ECG / external cardiac monitors

Extent of late gadolinium enhancement (LGE) on CMR / extensive LGE ≥15% LV mass

Extensive LVOT calcification

Extracardiac conduit / Fontan conversion

Extracorporeal life support (ECLS) / ECMO / ventricular assist devices

Extracellular matrix expansion / remodeling / proteins / extracellular volume / fraction
Extreme heat / temperature exposure

Exposure to adversity (violence, trauma)

Exposure to cardiotoxic agents
Excessive alcohol intake

E-cigarettes / E-cigarette use / electronic nicotine delivery systems (ENDS) / vascular remodeling
EVOPACS trial

EWOLUTION trial

EXAMINE trial (alogliptin outcomes)

EXCEL trial

EX-DHF pilot study

EXTRACT-TIMI 25 trial

Expert consensus decision pathways for tobacco cessation
Fabry disease / Fabry’s disease cardiomyopathy

Familial aneurysm risk / familial thoracic aneurysm / familial thoracic aortic aneurysm (no identified gene) / familial thoracic aortic aneurysm and dissection (FTAD) / familial thoracic aortic dilatation / familial thoracic aortic disease (TAD) / familial thoracic aortic disease genetics

Familial cardiomyopathy / familial cardiomyopathies

Familial hypercholesterolemia (FH)

Familial inheritance (autosomal dominant pattern)
Factor Xa / factor Xa inhibitor / factor Xa inhibitors (DOACs: apixaban, rivaroxaban, edoxaban, enoxaparin)

FDA adverse event reporting in anticoagulation therapy

Fibrin / fibrinogen / fibrinolysis / fibrinolytic therapy / fibrinolytic agents / fibrin-specific fibrinolytic agents / fibrinolytics
Failing left ventricle / failing right ventricle

Failure to rescue

Filling pressure / filling pressures (e.g., left-systolic filling pressure)
FALD (Fontan-associated liver disease) / fenestration-associated liver disease

Fetal complications / counseling / death / echocardiography / growth effects / growth retardation / intracranial bleeding / malformations / monitoring / outcome / screening

Fertility / family planning in ACHD patients
Failed reperfusion

Failed surgical bioprosthetic valves

False lumen / false lumen expansion / flow / hemorrhage / diameter >20–22 mm / thrombosis

Femoral access / femoral artery access / femoral cannulation / femoral endarterectomy / femoral pulse / femoral pulse delay / femoral vascular access

Femoropopliteal arterial disease / segment / bypass / lesions / angioplasty / disease

Fenestrated aortic repair / fenestrated closure / fenestrated endovascular aortic repair / fenestrated endovascular device / fenestrated stent graft / fenestrated surgical repair / fenestrated transcatheter device / fenestrated/branched endovascular procedures (FEVAR/BEVAR) / fenestrated/endovascular aneurysm repair (FEVAR/EVAR) / fenestrated/obstructive membrane orifice / fenestrated-branched endograft / fenestrated-branched endovascular aortic repair (FEVAR)

Focal aortic aneurysm / pseudoaneurysm / dissection / focal atherosclerotic lesions / focal atrial tachycardias / focal impulse modulation / focal intimal disruption / focused intimal disruption (FID)

Flail leaflet / flail tricuspid leaflet
FDG-PET / FDG-PET/CT / fluorodeoxyglucose positron emission tomography / fluorodeoxyglucose–positron emission tomography

FFR – fractional flow reserve / FFR-derived from CT angiography (FFR-CT) / FFR-guided PCI / FFR-guided PCI (≤0.8)

Flow assessment / flow quantification / flow diagrams / flow diagrams for cardiac decision pathways

Fixed radiographic imaging system and flat-panel fluoroscopy / fluoroscopy
FAME study / FAME-2 trial (fractional flow reserve vs angiography for multivessel evaluation)

FAUST trial (femoral arterial access with ultrasound)

FINT-STEMI trial

FLUVACS study (flu vaccination in acute coronary syndromes)

Fincv study

FAST-MI program
Felodipine

Fentanyl

Fenofibrate

Ferric carboxymaltose (iron therapy in HF with iron deficiency)

Fluvastatin (40–80 mg, oral, XL, bid)

Flecainide / flecainide (antiarrhythmic) / FLEXENIDE / FLEC-SL trial (short- vs long-term antiarrhythmic)

Fish oil / supplementation

Fibrates
Fluid administration / balance / management / input-output monitoring / restriction / removal rate / resuscitation / overload / retention / shifts / status / fluid-retention risk factors in diabetes treatment

Fick cardiac output / Fick method
Fall risk

Fatigue

Female sex / female predominance / sex-specific differences / female under-diagnosis of HCM / female-sex cardiovascular risk

Financial strain
Follow-up after discharge

Follow-up and monitoring

Follow-up and monitoring of bicuspid aortic valve

Follow-up aneurysm-related mortality

Follow-up appointments

Follow-up arrhythmia monitoring

Follow-up assessment

Follow-up echocardiography

Follow-up exercise testing restriction

Follow-up imaging in myocarditis

Follow-up imaging intervals (1 month, 6 months, 12 months, annually, every 5 years)

Follow-up interval recommendations (e.g., 3‑month CMR, 196‑day imaging)

Follow-up intervals / outpatient, ECG, TTE

Follow-up intervals (physiological stages A–D, asymptomatic severe/moderate AS, isolated branch pulmonary artery stenosis)

Follow-up studies / treatment outcomes
Fontan circulation / Fontan surgery / univentricular physiology

Fontan circulatory failure / Fontan failure / obstruction / pathway stenosis

Fontan completion / procedure / revision / conversion / total cavopulmonary Fontan

Fontan conduit stent-angioplasty / pathway conduit (extracardiac conduit)

Fontan palliation / Fontan physiology / Fontan patient / Fontan pressure / Fontan outcomes network

Fontan-associated complications / thrombosis / thrombus / liver disease (FALD) / portal hypertension / transplantation indications / screening

Fontan-adult Brompton clinical score
Functional assessment / structural cardiac assessment / functional and anatomic testing modalities

Functional capacity (exercise capacity, age- and sex-adjusted, peak VO₂, dyspnea on exertion, improvement, assessment)

Functional class (NYHA/WHO, assessment, improvement post-pulmonary valve replacement)

Functional coronary assessment / functional ischemic mitral regurgitation / functional tricuspid regurgitation (secondary to chronic AF) / functional stenosis / functional vs structural valve causes

Functional limitation / functional limitation grading / of claudication / provocable LVOTO, abnormal BP response, arrhythmias, etc.

Functional outcome / functional outcomes / functional status (decreased, exercise tolerance, HF, mobility limitations, walking performance metrics) / functional status and limitation / functional status decline in PAD / functional status improvement / functional status measures in elderly cardiac patients

Functional indices (e.g., NYHA class)

Functional domain / functional impairment / functional decline / functional exercise capacity
Frailty / frailty assessment / frailty indices / frailty score

Frailty as risk factor for poor self-care / impacting survival <1 year / predictor of outcomes in CAD / immobility / fragile tissue integrity / sarcopenia (muscle loss)

Frailty in ACHD / chronic heart failure
Fondaparinux

Furosemide / oral loop diuretic
Fractional area change

Fractional flow reserve (FFR) / FFR vs angiography / FFR-guided PCI / trials: FAME, FAME-2, FRAME-AMI, FAMOUS-NSTEMI

Fractional shortening

Fragmented QRS complex

Forward cardiac output / forward stroke volume
Forced expiratory volume in 1 second (FEV1)
FOURIER study / trial (PCSK9 inhibition in high-risk patients)

Functional assessment in elderly MI patients with multivessel disease (FIRE trial)

Freedom study / trial
Frozen elephant trunk (FET) / procedure / repair / technique

Future baffle occlusion

Fusiform aneurysm
Fungal aortitis / fungal endocarditis / fungal prosthetic valve endocarditis / fungal infection
Food access / food security / food effect (high-fat, high-calorie meal)

Food insecurity / screeners

Fried foods
Fresh frozen plasma (FFP) / in over-anticoagulation

Fourier study – cardiovascular outcomes research

Four-dimensional CT imaging (4D CT) / 4D flow MRI

Four-factor prothrombin complex concentrate (PCC)

Friedewald equation (LDL-C estimation)
Fourth heart sound

Fourth primitive dorsal aortic arch

Free wall rupture

Freedom from recurrent moderate/severe MR / freedom from reoperation

Future directions in PAD treatment

Future research directions (HF)

Future research needs (CCD)
Gadolinium enhancement (cardiac MRI)

Gadolinium-based contrast agents / media

Gated cardiac CT

Four-dimensional CT imaging (4D CT) / 4D flow MRI
Global longitudinal strain (GLS)

Gene carriers (HCM genetics) / gene variant carriers

Gene expression profiling / gene-expression profiling (cardiac)

Gene therapy (cardiac) / gene-based therapy / gene-specific therapeutics / gene-based management

Genetic aortopathy / genetic aortic disorder / genetic aortopathies

Genetic and pathobiological causes of valve dysfunction

Genetic associations / genetic determinants / genetic factors / gene-by-environment interaction

Genetic evaluation / referral / genetic evaluation for high-risk phenotypes / cardiomyopathy / thoracic aortic disease

Genetic counseling (pre-pregnancy / preconception / for inherited aortopathies / for myocarditis / for congenital heart disease / cascade screening)

Genetic testing (cardiogenetics / multigene panel / exome sequencing / syndromic features / family history / HCM-associated variants / TTR mutation / inherited cardiovascular disease / thoracic aortic disease / cardiomyopathy / arrhythmia genes / ion-channel disorders)

Genetic testing outcomes / genetic variant re-analysis / re-contact guidelines

Genetic predisposition / risk / penetrance / susceptibility / triggers

Genetic sarcomere variants / mutations (LOX, SMAD6, ACTA2, MYLK, MYH11, PRKG1, MLY2, titin, lamin A/C, TTR, other HCM or aneurysm-related genes)

Genotype / genotype-positive / genotype-negative / genotype-phenotype correlation / genotype-positive screening of family members / genotype-based risk stratification

Genomic/locus identification for AF / GWAS for AF / polygenic risk score / genetic susceptibility loci

Genetically inherited heart diseases / genetics / heritability / genetics-mediated risk stratification


Geriatric syndromes (frailty, mobility impairment, multicomplexity, depression, nutrition risk, etc.)

Geriatric 5Ms (mentation, mobility, medications, multicomplexity, what matters)

Geriatric nutritional risk index (GNRI)

Geriatric depression scale (GDS ≥ 6)

Gender / sex / gender differences / gender disparities / gender-identity disparities

Gender differences in aortic aneurysm growth and outcomes / rupture risk / imaging limits

Gender-specific risk models

Gender-affirming therapies (impact on arrhythmia, ACHD)

Gastrointestinal bleeding / gastric bleeding / intestinal bleeding

Gastrointestinal malignancy

Gastric bypass surgery

Gastric / intestinal absorption of P2Y12 inhibitors

Food access / food security / nutrition considerations

Green tea extract (observational therapy)

Glucose control / glycemic control / HbA1c targets / abnormal glucose / diabetes management

Glucose-lowering medical therapy (GDMT / guideline-directed therapy / glucose-directed therapy / glycemic-controlled disease management)

GLP-1 receptor agonists / glucagon-like peptide-1 receptor agonists (e.g., liraglutide, semaglutide, exenatide, lixisenatide, tirzepatide) / GLP-1 RA cardiovascular outcome agents

SGLT2 inhibitors

Glycemic treatment strategies / guidelines / agents affecting HF risk (metformin, insulin, sulfonylureas)

Glycated hemoglobin (HbA1c)

Graft patency (primary, assisted primary, secondary) / graft thrombectomy / graft surveillance

Graft failure / graft dysfunction / graft defect / graft misalignment / graft migration / graft porosity / graft infection / graft-related complications / graft enteric erosion / graft explant / graft revision / graft site inflammation

Graft type comparison (prosthetic vs autogenous)

Growth rate of aneurysm / AAA / aortic aneurysms (mm/year, ≥0.3–0.5 cm/year)

Galectin-3

Garfield-AF risk score / score

GRACE risk score / GRACE >140

GDF-15 (growth differentiation factor-15)

Goals of care (symptom relief, QoL, life prolongation)

GALILEO trial / GAUSS-3 trial / GISSI-HF trial / GISSI-Prevenzione trial / Global LEADERS trial / GET WITH THE GUIDELINES (GWTG) registry / GWTG-HF registry / GOALS study

Global burden of disease (GBD) cardiovascular studies / references / data on coronary disease

Global vascular guidelines on chronic limb-threatening ischemia

Global use of strategies to open coronary arteries (GUSTO) / GUSTO classification

Group-oriented arterial leg study (GOALS)

Gangrene / gluteal ischemia

GCM – giant cell myocarditis / giant-cell myocarditis / giant cell aortitis / giant cell arteritis (GCA)

General anesthesia / general or epidural anesthesia (peri-operative risk / during delivery)

General cardiologists / geographic availability of ACHD cardiologists

Geographic disparities (urban vs rural, clinician shortages, isolation)

Genital / genitourinary infections / mycotic infection

Glomerular filtration rate (GFR) / glomerulonephritis

Gout / gout and gallstones (e.g., bempedoic acid adverse effect)

GORLIN equation / formula (mitral area calculation)
GUIDE-HF trial / study

GUIDE-IT (guiding evidence-based therapy using biomarker-intensified treatment) / predictive model

GUSTO trial / GUSTO-I trial (global utilization of streptokinase and tPA) / GUSTO moderate or severe bleeding

GWTG-HF (Get With The Guidelines – Heart Failure) registry / risk score
G-protein–coupled receptor blockers (ARNI)